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Prions are infectious proteins that form transmissible, self-propagating 
amyloids that convert protein from its normal state into the prion state. The 
accumulation of amyloid is the causative agent of several neurodegenerative 
diseases, for instance, Huntington’s disease, which is caused by a 
polyglutamine expansion in the huntingtin (Htt) protein. In this study, a yeast-
based Huntington’s disease model was created to investigate the mechanism 
of amyloid toxicity and how nuclear genes modulate this toxicity. The model 
amyloid used was Rnq1, a transferable epigenetic modifier which is able to 
form a prion known as [PIN+]. [PIN+] is known to enhance the formation of 
polyglutamine aggregates in yeast. In this study, a series of cellular assays 
were employed to determine the mechanism of Rnq1-mediated cytotoxicity 
and compared with polyglutamine-rich-protein-mediated cytotoxicity 
dependent upon the [PIN+] prion. In [PIN+] cells RNQ1 overexpression leads 
to a significant increase in the production of reactive oxygen species (ROS). 
Furthermore, overexpression of RNQ1 resulted in a nuclear migration defect 
in [PIN+] cells. Upf1 (Up-frameshift protein 1), a highly conserved protein that 
plays an important role in nonsense-mediated mRNA decay, was found to 
modify amyloid toxicity. In a XSIǻ deletion strain, both Rnq1 and 
polyglutamine-rich-protein-mediated cytotoxicity were suppressed in a [PIN+] 
background. To further study the novel role of Upf1 in amyloid toxicity, a 
combination of cell biological and genetic approaches were being employed. 
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1.1 Common structure of amyloid and amyloid fibril formation 
 
Over the past four decades, deposition of amyloid leading to systemic 
amyloidosis in the body was thought to be the major causative agents in a 
number of fatal neurodegenerative diseases such as Alzheimer's disease, 
Parkinson's disease, Huntington disease and Creutzfeldt-Jakob disease (Roth 
et al., 1966). Recent evidence indicates that soluble amyloid oligomers which 
are also known as prefibrillar oligomers may be the toxic protein species in 
amyloid pathogenesis, rather than the mature amyloid fibrils, for example, 
amyloid plaques which are insoluble and highly organised by the repeating ȕ-
sheets structure (Hardy et al., 2002, Lesne et al., 2006). 
 
The term amyloid arises from the combination of amylo (starch) and oid (like) 
representing the mistaken origin of identification of the substance as starch 
that was based on inaccurate staining techniques. Amyloids were first 
discovered by Astbury (Astbury et al., 1935). Amyloids are insoluble misfolded 
fibrillar proteins which are able to polymerize to form a cross-ȕ structure either 
in vivo or in vitro (Nilsson, 2004). The most characteristic feature of amyloid is 
the cross-ȕ structure which can be visualised by particular dyes such as 
Congo red and thioflavin. The cross-ȕ structure enhances the stability of 
amyloid fibrils, the tendency to form polymerized structures and their self-
seeding property (Nelson et al., 2005).  
 
Aggregation of misfolded proteins can form different protein assemblies like 
oligomers, amorphous aggregates, amyloid fibrils and plaques. Different types 
of misfolded proteins can give rise to prefibrillar oligomers acting as soluble 
intermediate aggregates in the amyloid fibril formation pathway. These protein 
particles are able to form either amorphous aggregates or amyloidogenic 
nuclei by conformational change (Figure 1.1). An amyloidogenic nucleus can 
initiate the formation of amyloid fibrils which are insoluble and have a highly 





That amyloid polymerization is amino acid sequence-dependent implies that 
mutations in the sequence may reduce or block amyloid self-assembly. 
Amyloid polymerization can be achieved by two types of intermolecular forces, 
hydrogen bonding or hydrophobic interactions depending on two distinct 
amyloid-forming polypeptide sequences (Pawar et al., 2005). A sequence 
enriched in glutamine can enhance the cross-ȕ structure by forming hydrogen 
bonds. In this case, glutamine content is thought to correlate with toxicity. For 
instance, in Huntington disease, the longer the polyglutamine sequence is, the 
earlier the age of onset (Morley et al., 2002). Despite polyglutamine 
sequences, a non-repeated sequence can also illuminate the cross-ȕ 





Figure 1.1 Aggregation of misfolded protein can generate amyloid fibrils and 







1.2 Overview of prions 
 
 
1.2.1 Definition of a prion protein 
  
In 1982, Stanley Prusiner proposed the word ‘prion’ derived from 
‘proteinaceous’ and ‘infectious’ to describe an unusual amyloid protein which 
can transmit genetic information by means of unique mechanisms other than 
changes in the underlying DNA sequence (Prusiner, 1982). Prions are 
infectious agents that are believed to cause a number of neurodegenerative 
diseases in humans, for example, Creutzfeldt-Jacob Disease (CJD) (Prusiner, 
1998). One of the most unusual characteristics of the prion diseases is that it 
can be transmitted in the absence of DNA or RNA according to Prusiner’s 
‘protein-only’ hypothesis. Prions are also found in fungi such as 
Saccharomyces cerevisiae (Wickner, 1994) and Podospora anserina 
(Coustou et al., 1997). 
 
 
1.2.2 The properties of a prion protein 
 
All prion proteins in mammals or fungi can exist in one of two states: a native 
non-prion form ([prion-]) or a heritable prion form ([PRION+]). The prion-free 
indicates that the protein has normal cellular activity and is in its soluble form, 
while the prion form is not able to maintain its normal function and aggregates 
into amyloid deposits. The conformational change between a natural protein 
and its prion state may lead to different effects on the protein’s function and 
eventually impact on the host cell phenotype. In fungi prions can also serve as 
novel regulators of the cellular phenotype of the host cell (Tuite and Serio, 
2010). The second difference between the two states is that the [prion-] form 
is sensitive to protease treatment whereas the [PRION+] form is protease 
resistant. Prions of the same protein can have distinct conformational isoforms 
which is known as variants. Different variants lead to the same disease, but 
different disease characteristics (Aguzzi et al., 2007). For example, the 
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causative agent of transmissible spongiform encephalopathies (TSEs), PrPSc, 
can form distinct aggregates which cause disease with distinct characteristics, 
such as incubation period, pattern of PrPSc distribution, and regional severity 
of histopathological changes in the brain (Poggiolini et al., 2013). In addition, 
all prions are amyloids, but most amyloids are not prions; i.e. most disease-
associated amyloids are not infectious and cannot be transmitted between 
individuals (Wickner et al, 2000).  
 
 
1.2.3 Discovery of prions in mammals 
 
The first of prion diseases to be described was scrapie, a disease of sheep 
recognized for over 250 years. The symptoms of the disease are 
hyperexcitability, itching, and ataxia that eventually leads to paralysis and 
death (Gordon, 1946). In mammals, it was discovered that an infectious agent 
named as PrP (prion protein), which may occur both in infectious and non-
infectious forms, was involved in causing a class of fatal neurodegenerative 
diseases, the Transmissible Spongiform Encephalopathies (TSE). PrP is a 
cellular protein whose function is still unknown. PrPSc refers to the infectious 
[PRION+] form of PrP while PrPC represents the normal [prion-] form of the 
protein. PrPC is a soluble glycoprotein which is found anchored to the 
extracellular membrane of several cell types whereas PrPSc, the prion form of 
PrPC is insoluble, partially resistant to proteolysis, and forms amorphous and 
amyloid-like aggregates which lead to its abnormal accumulation in tissues 
resulting in severe cellular damages (Prusiner, 1998). PrPSc is capable of 
converting PrPc proteins into its infectious state by triggering a change in the 
conformation of PrPc (Figure 1.2). The assembly of prions into amyloids is a 
self-perpetuating process that displays a typical nucleation-elongation reaction. 
The pre-existing PrPSc acts as a seed to catalyse amyloid polymerization 
leading to the disease (Caughey et al., 2009).  
 
The PrP amino acid sequence of its N-terminus is highly conserved in 
mammals (Goldfarb et al., 1991). The PrPSc protein has a structure with a high 
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proportion of ȕ-sheets which usually binds to Congo red (CR) and thioflavin-T 
(Th-T) dyes whereas PrPc is highly flexible consisting of an unstructured N-
terminal tail and a globular C-terminal region rich in Į-helices (Riek et al., 
1996) i.e. there is a distinct difference in their conformation (Pan et al., 1993). 
Moreover, it was established that PrPSc was responsible for the formation of 
amyloid fibers and neurodegeneration. Amyloid fibrils are also rich in ȕ-sheet 
structures and are protease-resistant and have been linked to a number of 
different human neurodegenerative diseases (Prusiner, 1998).  
 
 
1.2.4 Discovery of prions in fungi 
 
Yeast prions were identified with genetic studies in Saccharomyces cerevisiae. 
During the last five decades, only [PSI+] (Cox, 1965) and [URE3] (Lacroute, 
1971) have been described but whose molecular basis was poorly understood. 
The initial discovery of [PSI+] was made by Brain Cox (Cox, 1965) in a strain 
auxotrophic for adenine due to a nonsense mutation. The ade2-1 mutation, a 
premature UAA terminator, resulted in the accumulation of a red pigment 
derived from the Ade2 substrate. When the [PSI+] was present, the read-
through of the premature UAA stop codon in the ade2-1 gene was efficient 
enough to allow cell growth without adenine. [Het-s] is the only prion 
discovered in a filamentous fungus, Podospora anserine, and was the first 
prion protein whose bacterial inclusion bodies were shown to display amyloid-
like properties. (Table 1.1). Recent studies revealed that there are more than 
20 newly discovered prions in S. cerevisiae (Alberti et al., 2009).  
 
 
1.2.5 Genetic criteria used to identify a prion 
 
Wickner has proposed three genetic criteria to identify a fungal prion (Wickner, 
1994) and most prions in fungi satisfy all three criteria, whereas nucleic acid-





Table 1.1 Prions and its corresponding protein and prion-associated 









Species Cellular function Prion phenotypes References 
PrPSc PrPc mammals Unknown Neurodegeneration 
and death 
(Prusiner, 1998) 




Poor in nitrogen 



















Unknown Facilitating de novo 
conversion of [PSI+] 
and [URE3] 
(Sondheimer et al., 
2000)  
(Derkatch et al., 
2001) 
[SWI+] Swi1 Saccharomyces 
cerevisiae 





(Derkatch et al., 
2001) 
(Du et al., 2008) 







(Patel et al., 2009) 







(Alberti et al., 2009) 






(Volkov et al., 
2002) 
(Rogoza et al., 
2010) 











Figure 1.2 The overview of prion formation and propagation  
Proteins in their [PRION+] state are capable of converting [prion-] (i.e. normal protein) 
into the [PRION+] form. [PRION+] molecules can rearrange and generate insoluble 
amyloid deposits by polymerisation. Propagons derived from the process of 
fragmetation are able to facilitate the conversion of [prion-] into the [PRION+] state.  
 
 
Firstly, the process of converting the normal protein ([prion-]) to its abnormal 
form ([PRION+]) should be reversible which means if the infectious form of the 
protein can be eliminated from a cell, it can also reappear by spontaneous 
conversion no matter what treatment was used for eliminating the underlying 
non-chromosomal element from the cell. The reversible curability can be 
achieved by growing cells in the presence of 3-5 mM guanidine hydrochloride 
(Tuite et al., 1981). In addition, maintenance of the [PRION+] form requires the 





Secondly, overproduction of the protein can induce the de novo appearance 
of the [PRION+] form indicating that the higher the concentration of the cellular 
protein is, the higher the efficiency of generating the prion de novo. 
 
Thirdly, the phenotype of [PRION+] cells is similar to the phenotype of cells 
expressing a corresponding mutated and non-functional version of the protein. 
In addition, prions should show non-Mendelian inheritance i.e. the 
transmission of prions at meiosis is in a non-Mendelian manner.  
 
 
1.3 Prion propagation mechanism 
 
A well-characterised property of prions is that the [PRION+] form can 
propagate by the mechanism of binding and converting protein molecules 
existing in its normal [prion-] state, to the abnormal [PRION+] form. Two 
hypotheses have been proposed to explain the self-propagation of prions. 
One of the possible mechanisms of prion propagation in fungi is the “template-
directed refolding” model (Figure 1.3A) that proposes that a prion protein in its 
[PRION+] form acts as a template to convert the normal soluble protein ([prion-
]) to its infectious state. The “template” was thought to be a polymer of prion 
protein molecules and this resulted in the assembly of the amyloid fibrils via 
“conformational conversion” (Griffith, 1967; Prusiner, 1991). In addition, the 
spontaneous conversion between the normal soluble form ([prion-]) and the 
prion conformer ([PRION+]) of a prion protein is thought to be prevented by a 
high activation energy barrier (Cohen and Prusiner 1998).  
Another hypothesis for prion self-propagation is the “seeded polymerisation” 
model (Figure 1.3B) that suggests that the formation of the infectious seed is 
the key component of the whole process. The infectious seeds are generated 
by accumulation of several monomeric prion conformers and consequently 
drive the polymerization of other prion conformers to form amyloid deposits. 
New seeds are generated by fragmentation of the amyloid aggregates and the 
seed is recruited for continued prion propagation. This fragmentation could be 






Figure 1.3 Two proposed models for de novo conversion and prion 
propagation. (A). The “template-directed refolding” model in which a prion conformer 
serves as a template for the conversion of a prion protein from its normal soluble 
form ([prion-]) to its prion form ([PRION+]). (B). The “seeded polymerisation” model 
suggests that there is an equilibrium between the ([prion-]) form and ([PRION+]) form 
of the prion protein since the monomer of ([PRION+]) is unstable and can easily 
switch the equilibrium towards ([prion-]). An oligomer of ([PRION+]) can generate an 
infectious seed, or propagon, which is capable of recruiting further monomeric 
([PRION+]) to form amyloid aggregates. Fragmentation of the amyloid deposits can 
generate several infectious seeds for further conversion and prion propagation. 
 
 
1.3.1 Role of cellular factors in prion propagation 
 
Fungal prions are not able to propagate without an input from cellular factors. 
In particular prion-specific chaperones play a very important role in prion 
propagation. Chaperones are able to prevent proteins from aggregating and 
to disaggregate proteins that have misfolded. For instance, the molecular 
chaperone Hsp104, is involved in the propagation and maintenance of the 
[PSI+] prion (Chernoff et al., 1995). Hsp104 is an ATPase that is capable of 
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binding to the aggregated proteins and re-solubilizing the protein aggregates 
in the presence of ATP (Glover et al, 1998). Yeast cells cannot propagate the 
[PRION+] form of a protein if the Hsp104 ATPase activity is inhibited (Chernoff 
et al., 1995).  Moreover, Hsp104 seems to form a chaperone complex with 
members of the Hsp40 and Hsp70 protein families to allow the propagation of 
prions to proceed successfully (Glover et al, 1998; Jones and Masison, 2003). 
For example, Hsp104 and GroEL play an important role in the regulation of 
PrP conformation. It was suggested that the conversion of PrPC to PrPSc is a 
two-step process by kinetic analysis. PrPC was firstly converted to a pelletable 
state in the presence of GroEL and PrPSc via recruitment of intermediate PrP 
and then converted to PrPSc once the PrP pelletable state was established 
(DebBurman et al., 1997).   In mammals, RNA molecules are thought to act as 
cellular co-factors for PrPSc to convert PrPc proteins into its infectious state, 
but there is no evidence for this in yeast (Deleault et al., 2003).  
 
 
1.3.2 Role of chaperones in prion propagation 
 
Previous studies established that Hsp104 cannot fully perform its function as a 
disaggregase without joining at least two other chaperones, Ydj1 belonging to 
the Hsp40 family and Ssa1 a member of the Hsp70 family. There is an 
interaction between Yjd1 and Hsp104 while Ssa1 interacts with Ydj1 (Glover 
et al, 1998, Cyr et al, 1992). Following the discovery that Hsp104 is not 
capable of restoring the activity of a denatured protein alone, it emerged that 
Ssa1 functions to help Hsp104 to refold the protein aggregates and this also 
facilitates the process of prion propagation (Allen et al., 2005). Ssa1 and Ydj1 
were thought to stabilize and fold the protein at a first step followed by Hsp104 
that further promote the folding of the protein (Glover et al, 1998). Moreover, 
Ssa1 plays a key role in the prion curing process of [PSI+]; for example, it was 
reported that increased levels of Ssa1 reduce [PSI+] elimination by Hsp104 
overexpression indicated that there is an antagonistic effect of Ssa1 on 
Hsp104 when both Ssa1 and Hsp104 are overexpressed. In addition, 
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overexpression of Ssa1 can eliminate [URE3], whereas overexpression of 
Ssa1 has no effect on [PSI+] propagation (Schwimmer and Masison, 2002).  
 
1.4 Sup35 and the [PSI+] prion 
 
 
1.4.1 Variants of the [PSI+] prion 
 
[PSI+], as one of the best studied yeast prions, is the prion form of the Sup35 
protein. Sup35 is a translation termination factor that is responsible for 
recognising a termination codon and cleaving the completed peptide from 
peptidyl tRNA (Stansfield et al., 1995). The read-though of stop codons is 
increased when Sup35 is present in the [PSI+] form suggests that its 
translation termination activity is attenuated. 
 
The [PSI+] prion can exist as one of a number of different variants which were 
first identified by their differential effects on nonsense suppression. In [PSI+] 
cells, the Sup35 protein forms aggregates resulting in the read-through of the 
ade1-14 nonsense mutation. The ade 1-14 mutation is a mutation in a gene 
that encodes an enzyme required for adenine synthesis. This mutation results 
in adenine auxotrophy i.e. the yeast strain cannot survive unless adenine is 
provided in the growth medium. The ade1-14 mutation gives red yeast 
colonies that are adenine deficient if the [PSI+] prion is not present. This is 
because the defect in adenine biosynthesis causes the accumulation of a 
pathway intermediate that develops into a red pigment. On the other hand, 
white yeast colonies are formed due to the read-through of the ade1-14 
nonsense (UGA) mutation. Strong [PSI+] variants generate white colonies on 
adenine deficient media since they show a high efficiency of ade1-14 
nonsense suppression whereas the weak [PSI+] variants generate pink 
colonies because of their lower efficiency of ade1-14 nonsense suppression 






Figure 1.4 The Sup35 protein leads to read-through of mRNA stop-codons in 
[PSI+] cells. The Sup35 (eRF3) binds to Sup45 (eRF1) to form an active complex in 
[psi-] strains. mRNA translation is terminated and the polypeptide is released since 
the Sup35p-Sup45p complex recognise the stop codon on mRNA. By contrast, 
Sup35 is insoluble in its [PSI+] state resulting in read-through of mRNA stop codons 
and an increased polypeptide synthesis. 
 
Sup35 consists of three domains: the N-terminal domain, the middle M-
domain and the C-terminal domain. The N-terminal domain is rich is glutamine 
(Q) and asparagine (N) and is primarily responsible for prion formation and 
aggregation (Derkatch et al., 1996). The M-domain is involved in prion 
maintenance but not critical for prion formation (Liu et al., 2002). The C-
terminal domain plays an important role in translation termination and 
therefore is essential for growth (Ter-Avanesyan et al., 1993). Moreover, 
recent studies have revealed that the C-terminal domain is not only essential 
for cell viability but also prion propagation (Kabani et al., 2011).  
 
 [PSI+] cells can be cured of the prion form of Sup35 after guanidine 
hydrochloride (GuHCl) treatment or deletion of the HSP104 gene (Tuite et al, 
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1981; Chernoff et al., 1995). [PSI+] cells are found to be resistant to a variety 
of physical and chemical stresses and also more resistant to heat and ethanol 
stresses in certain strains (Eaglestone et al., 1999; True et al., 2000). 
Overexpression of the prion forming domain of Sup35 causes the de novo 
formation of [PSI+] which can be significantly increased by the presence of the 
[PIN+] prion (Derkatch et al., 1997). 
 
 
1.4.2 Sequence features that define a prion-forming domain 
 
Studies of the structure and amino acid sequences of the various yeast prion 
proteins have suggested that the prion-forming domain (PrD) has two 
diagnostic features. One is conformational flexibility of the region and the 
other feature is that this region is particularly rich in glutamine and asparagine 
residues (Scheibel and Lindquist, 2001; Nazabal et al., 2003; Alberti et al., 
2009).     
 
The prion-forming domain of Sup35 is located in its N terminus (Figure 1.5) 
and contains two distinct elements: a QN-rich region (QNR) and a region 
containing a series of oligopeptide repeats (OPR). The QNR element is 
composed of 40 residues that are rich in uncharged polar amino acids namely 
glutamine and asparagine. The amino acids between residues 8-26 are 
crucial for prion propagation (DePace et al. 1998). Unlike other cellular 
proteins which are rich in aliphatic residues, the QNR element of the prion 
protein has a low number of aliphatic amino acids such as glycine, leucine 
and valine. The QN-rich region (QNR) by acting as an “amyloid core”, plays a 
key role in prion propagation. This was demonstrated by showing that if one of 
the uncharged polar residues, glutamine or asparagine, is replaced by the 
polar residues, for instance, aspartic acid in the QNR region, this can result in 
a decrease in joining the pre-existing prion aggregates or preventing further 



















Figure 1.5 Domain architecture of Sup35 protein. (a)The Sup35p protein contains 
three domains, a N-terminal domain (amino acid 1-123), a middle domain (amino 
acid 123-254) and the C-terminal domain (amino acid 254-685). The prion forming 
domain (amino acid 1-97) of Sup35 consists of two elements: the glutamine (Q) and 
asparagine (N) rich (QNR) region (amino acid 1-40) which initiates the process of 
protein aggregation, and the oligopeptide repeats (OPR) region (amino acid 41-97) 
containing five a-repeats (labelled 1-5) that are responsible for prion propagation. 
Different colours represent different regions of amino acid sequence of Sup35p. (b) 
The sequence of QNR region (amino acids 1-40). (c) The sequence of OPR region 
(amino acids 41-97). 
 
 
Another element of the prion-forming domain is the oligopeptide region (OPR) 
which contains 57 residues that is able to form highly stable amyloid 
aggregates. In this region, a heptapeptide sequence GGYQQYN is thought to 
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generate a hydrophobic environment of the protein thus increasing the 




1.5 Rnq1 and [PIN+] prions  
 
 
1.5.1 [PIN+] prion and [PIN+] variants 
 
The [PIN+] prion was first discovered from studies on the de novo formation of 
the [PSI+] prion (Derkatch et al., 1997). It was reported that [PSI+] strains 
could generate two types of [psi-] clones when cured by guanidine 
hydrochloride. In one type of [psi-] population, [PSI+] could be generated by 
Sup35 over-expression, while in the other [psi-] population it could not. Due to 
the difference between these two distinct [psi-] populations, the derivatives 
that could be induced to [PSI+] were designated [PIN+] for [PSI+] inducibility 
whereas the derivatives which maintained the [psi-] phenotype were 
designated as [pin-] (Derkatch et al, 1997). Subsequently, it was demonstrated 
that the [PIN+] prion is capable of increasing the de novo formation of not only 
the [PSI+] prion, but also the [URE3] prion (Bradley et al., 2002). However, the 
[PIN+] prion is not required for the continued propagation of the PSI+] prion 
(Derkatch et al, 2000). 
 
[PIN+] is usually the prion form of the Rnq1 protein which is so named 
because the Rnq1 protein is rich in glutamine and asparagines residues 
(Derkatch et al., 2001; Osherovich et al., 2001). The Rnq1 protein consists of 
two domains: an N-terminal domain and a QN-rich C-terminal domain which 
constitutes the prion-forming domain (PrD) of Rnq1. The function of Rnq1 
protein still remains unknown (Sondheimer and Lindquist, 2000). Recent 
studies have revealed that [SWI+] is capable of facilitating the de novo 




As the [PSI+] prion, the [PIN+] prion can take up differential heritable variants. 
Such [PIN+] variants differ in several ways, their efficiency of promoting the de 
novo appearance of [PSI+] and [URE3] prions, the level of soluble and 
aggregated Rnq1 protein and the fluorescence pattern of Rnq1-GFP in the 
cytosol. Five variants of [PIN+] were originally identified and named as [pin-], 
low [PIN+], medium [PIN+], high [PIN+] and very high [PIN+] according to their 
distinct efficiency of [PSI+] induction (Bradley et al., 2002). Genetic studies 
have confirmed that distinct Rnq1 conformers define the different [PIN+] 
variants because the RNQ1 gene sequence in these variants is identical (G. L. 
Staniforth, personal communication). A recent study has revealed that [PIN+] 
variants differ mainly in their cross-seeding abilities, but not in their seed 
(propagon) numbers or in other features in promoting [PSI+] conversion 
(Sharma and Liebman., 2013). 
 
 
1.5.2 [PIN+] as a toxic amyloid model 
 
Studies focusing on fatal neurodegenerative diseases such as Alzheimers 
disease have revealed that amyloids are key pathogenic components of these 
diseases. However, whether amyloids cause toxicity and the associated 
neurodegeneration remains unknown. Moreover, whether amyloid per se is 
cytotoxic or protective is still unclear. To help elucidate the mechanism of 
amyloid toxicity, several yeast models have been developed to investigate the 
relationship between aggregation of amyloid and the toxicity of its 
corresponding amyloid protein aggregates. The three major models are based 
RQĮ-synuclein, polyQ and Rnq1. 
 
S. cerevisiae has been used as a model to elucidate the mechanism of toxicity 
associated with Huntington disease. Huntington disease is caused by the 
accumulation of expanded polyglutamine (polyQ) huntingtin protein molecules 
encoded by the huntingtin gene with CAG repeat expansions (Gutekunst et al., 
1999). Huntingtin molecules with expanded polyQ are more prone to 
aggregate into intracellular inclusion bodies and this leads to cell toxicity 
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(Scherzinger et al., 1997; Bates et al., 1998). Overexpression of the yeast 
prion protein Rnq1 can also lead to the formation of inclusion bodies similar to 
those observed in huntingtin with a polyQ expansion. Moreover, Rnq1 in its 
[PIN+] prion form is crucial for polyQ aggregation and consequently results in 
cell death (Meriin et al., 2002).  
 
The yeast model provides a useful approach to investigate polyQ-induced 
toxicity not least because there is a direct link between aggregation of the 
expanded polyQ domain and its cytotoxicity. In addition, Hsp104, one of the 
most important molecular chaperones in prion propagation (see Section 1.3), 
can affect polyglutamine toxicity either directly via modulation of polyglutamine 
aggregates, or indirectly through modulation of prions that interact with 
polyglutamine aggregation (Gokhale et al., 2005). Moreover, defects in 
Hsp104 function can lead to inhibition of seeding of polyQ aggregates (Meriin 
et al., 2002).   
 
[PIN+] can interact with other amyloidogenic proteins and facilitate their 
conversion into their amyloid conformation. It was reported that 
overexpression of Rnq1 is toxic when endogenous Rnq1 is pre-existing in the 
[PIN+] state (Douglas et al., 2008). This toxicity can be suppressed via 
interactions between a molecular chaperone namely Sis1 (Sondheimer et al., 
2001). Moreover, overproduction of Rnq1 is ineffective at enhancing prion 
conversions (Derkatch et al., 2001). 
 
 
1.6 Polyglutamine (polyQ) tract induced toxicity  
 
 
1.6.1 Huntington’s disease 
 
Huntington’s disease (HD) was first described as an autosomal dominant 
disease by George Huntington in 1872 (Huntington, 1872). HD is a fatal 
neurodegenerative disorder which is diagnosed by the selective loss of 
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medium spiny neurons in the striatum of HD patients. The most characteristic 
symptoms of HD include uncontrollable movement, neuropsychiatric 






Figure 1.6 Huntington disease is caused by an expansion of the number of 
copies of the Gln CAG codon. If the elongated CAG repeat is translated, it 
generates a protein with an expanded glutamine stretch. The number of CAG repeats 




Table 1.2. Classification of HD depending on the number of CAG repeats 
Number of 
CAG repeats (n) Classification 
Disease 
status 
Risk to  
offspring 
n<35 Normal Normal None 
35<n<40 Incomplete penetrant 
May or may not 
be affected 
50% 
n>40 Fully penetrant Diseased 50% 
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Genetically, HD is defined a ‘trinucleotide repeat disorder’ which is caused by 
an expansion in the number of a repeated trinucleotide (CAG) in the 
Huntingtin (HTT) gene.  The HTT gene (also known as the IT-15 gene) is 
located on the short arm of chromosome 4 (Walker, 2007). The CAG 
trinucleotide repeat encodes a polyglutamine (polyQ) tract in the huntingtin 
(htt) protein which varies in length between normal and diseased populations. 
Huntingtin is expressed in all human and mammalian cells, with the highest 
concentrations in the brain and testes (DiFiglia et al., 1995). Individuals with 
35 or less CAG repeats in the HTT gene are able to produce normal htt 
proteins while the diseased population with a sequence of 35 or more CAG 
repeats results in the production of abnormal htt proteins with a propensity to 
aggregate (Table 1.2, Fugure1.6) (Walker, 2007). Moreover, individuals with a 
large number of CAG repeats, usually of 60 or more CAG units, are 
diagnosed as juvenile HD (Nance, 2001). The longer the polyQ expansion, the 
more severe the disease and the earlier its onset. 
 
A huntingtin exon I fragment is found in huntingtin aggregates within neurons 
of HD patients and is sufficient to produce neurodegeneration in mouse 
models (Mende-Mueller et al., 2001). Similarly, Huntingtin exon I fragment 
with polyQ regions of different lengths were developed in many yeast models, 
which recapitulates the molecular basis of polyQ length-dependent toxicity 
(Krobitsch and Lindquist., 2000; Meriin et al., 2002). The huntingtin constructs 
of different yeast strains tested are related but differ in the nature of 
sequences flanking the polyQ region. Only Meriin’s model has been found to 
be toxic (Meriin et al., 2002). It was reported that the commonly used FLAG-
epitope (DYKDDDK) at the amino terminus of huntingtin exon I can unmask 
the toxicity of an otherwise benign polyQ protein, whereas the endogenous 
carboxyl-terminal polyproline region of huntingtin exon I can convert toxic 
proteins into nontoxic ones. This finding suggests that specific amino acid 
sequences flanking the polyQ region of huntingtin exon I greatly influence 






1.6.2 Polyglutamine (polyQ) tract induced toxicity 
 
In eukaryotes, a number of repetitive nucleotide triplets, CAG or CAA, vary in 
length resulting in the production of a chain of glutamine (Q) units referred to a 
polygutamine (polyQ) tract. A subdomain of neurodegenerative disorders 
known as polyglutamine (polyQ) disorders is caused by such an expansion of 
a triucleotide (CAG) repeat. The polyQ expansion was found associated with 
Spinal and Bulbar Muscular Atrophy (SMBA) in 1991 suggesting polyQ 
expansion plays an important role in a number of neurodegenerative disorders 
in addition to HD.  Subsequently, another seven genes with polyQ expansions 
were found to be the causative agents of specific neurodegenerative diseases 
including that was known before 1991, DentatoRubral and PallicloLuysian 
Atrophy (DRPLA) and six types of Spino-Cerebellar Ataxias (SCA-1, SCA-2, 
SCA-3, SCA-6, SCA-7 and SCA-17). 
 
PolyQ disorders have some features in common, such as that to be 
genetically inherited neurodegenerative disorders, toxic mutant proteins and a 
family of late onset and progress disorders.  Apart from these common 
features, polyQ tract expansions lead to selective neuronal dysfunction and 










The BNA4 gene encodes the yeast orthologue of the mammalian enzyme, 
kynurenine 3-monooxygenase (KMO), which is involved in the mitochondrial 
kynurenine pathway. Tryptophan is metabolised mainly through the 
kynurenine pathway. The key compound of the kynurenine pathway is 
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kynurenine (KYN) which can undergo two distinct pathways. The metabolite of 
one pathway is kynurenic acid (KYNA) while the metabollites of the other 
pathway are 3-hydroxykynurenine (3-OH-KYN) and quinolinic acid (QUIN) 
which are the precursors of NAD (Figure 1.7). 
 
KYNA is as an endogenous excitatory amino acid receptor blocker that links 
the nicotinic–cholinergic system and the KYN pathway in the brain (Hilmas et 
al., 2001). Increased levels of QUIN have been implicated in the 
pathophysiology of HD (Giorgini, 2008). An elevated level of 3-OH-KYN has 
been found in cells expressing a toxic mutant htt fragment (Giorgini et al., 
2005; Giorgini et al., 2008). and these three tryptophan metabolites (KYNA, 3-
OH-KYN and QUIN) are known as “neuroactive KYNs”. Imbalance of the 
kynurenine pathway metabolism is a key factor of pathogenesis in HD. The 
KMO protein has been identified as a drug target for HD that can be 
genetically or pharmacologically inhibited resulting in a reduced level of 3-OH-
KYN and QUIN and therefore reducing disease-relevant phenotypes (Tauber 
et al., 2011). 
 
Moreover, previous studies had revealed that BNA4 deletion was able to 
supress polyglutamine-rich-protein-mediated (Htt 103Q) cytotoxicity in a [PIN+] 
background (Giorgini et al., 2005). 
 
 
1.7.2 UPF proteins 
 
Upf proteins, Upf1, Upf2 and Upf3, are three key factors in the nonsense-
mediated mRNA decay (NMD) pathway. NMD is an evolutionary conserved 
cellular pathway that results in degradation of aberrant mRNA transcripts that 
carry premature termination codons (PTCs) and therefore prevents synthesis 
of harmful C-terminally truncated proteins. In Upf1, Upf2 or Upf3 mutants, 













The Upf1 protein (also known as Nam7 in yeast) is an ATP-dependent RNA 
helicase distributed in the cytoplasm (He and Jacobson, 1995). The Upf2 
protein (also known as Nmd2 in yeast) localises to the cytoplasm where it can 
interact with both the Upf1 and Upf3 protein (He et al., 1997). The Upf3 
protein also localises to the nucleus and is rich in basic amino acid residues 
while the Upf2 protein is rich in acidic amino acid residues (Shirley et al., 
1997). 
 
The Upf proteins act as a complex since deletions of single or multiple UPF 
genes lead to equivalent stabilization of aberrant mRNA transcripts. Recent 
studies have revealed that the Upf1 protein not only binds to the NMD 
substrates but a number of transcripts which are not involved in the NMD 
pathway (Zund et al., 2013). 
 
The two polypeptide release factors, eRF1 (Sup45) and eRF3 (Sup35), can 
interact with Upf proteins in yeast. Both eRF1 and eRF3 interact with Upf1 
while only eRF3 interacts with Upf2 and Upf3. Since UPF gene deletions 
promote nonsense suppression, the Upf proteins not only play a crucial role in 
NMD but also translation termination (Wang et al., 2001).  
 
 
1.8 Project aims 
 
The accumulation of amyloids is the key pathogenic component of several 
neurodegenerative diseases including Huntington’s disease, which is caused 
by a polyglutamine expansion in the huntingtin (Htt) protein. However, the 
molecular basis of amyloid toxicity is poorly understood. To reveal the 
molecular basis of pathogenesis of amyloid diseases, [PIN+] was chosen as a 
yeast-based toxic amyloid model system to determine the mechanism of 
toxicity and to identify how cellular factors can modulate this toxicity. In this 
study, a series of cellular and biochemical assays were employed to 
determine the mechanism of Rnq1-mediated cytotoxicity and compared with 
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polyglutamine-rich-protein-mediated cytotoxicity, both of which are dependent 
upon the presence of the [PIN+] prion. 
 
The overall aim of my project was to establish the mechanism of Rnq1 
overexpression-induced toxicity and compare the results with the expression 
of polyglutamine protein-mediated toxicity in yeast strains carrying different 
conformational variants of prion form of Rnq1.  
 
The three specific aims were:  
 
1. To analyse Rnq1-induced cytotoxicity in different [PIN+] variants when 
Rnq1 is overexpressed. The focus was to be on cell morphology, 
defects in cell growth, defects in nuclear migration and level of reactive 
oxygen species (ROS). 
 
2. To compare the toxicity of polyglutamine-rich-proteins and Rnq1 
overexpression in the different [PIN+] conformational variants  
 
3. To further study the mechanism of Rnq1 toxicity by using a 
combination of cell biological and genetic approaches in several strains 
carrying gene deletions that reduced toxicity. The deletion strain EQD¨ 
was previously identified as supressing polyglutamine-rich-protein-
mediated cytotoxicity in the [PIN+] background. Upf1, a highly 
conserved protein that plays an important role in nonsense-mediated 


















Chapter 2  
 





















2.1 Chemicals and reagents 
 
Risk assessments including COSHH were carried out for all procedures 
involving use of hazardous chemicals or equipment and suitable control 
measures were employed. All work involving genetically modified organisms 
and pathogens were performed in an ACDP category two laboratory. 
 
Table 2.1. Chemicals and reagents used in this study 
Materials Content Source 
Chemicals and 
reagents 
Ethanol, Ethylenediaminetetraacetic acid, 









XhoI, Hind III Promega, Roche, 
New England 
Biolabs 
Reaction kits QuikChange Lightning Site-Directed 





Media and amino 
acid drop-outs 
Complete Supplement Mixture (CSM) single 
drop-outs: CSM, -ade; CSM, -ura; CSM, -leu; 
Complete Supplement Mixture (CSM) double 




2.2 Growth media 
 
All components of the various growth media were weighted to two decimal 
places using a Sartorius MC1 LC620D balance (Sartorius). All components for 
liquid media were dissolved in ultrapure water produced by Direct-Q® 3 
Ultrapure Water System (Merck Millipore) and autoclaved at 126°C with an 11 
min cycle using a Prestige Medical benchtop autoclave. The autoclave was 
used to eliminate the risk of contamination from bacteria and other organisms. 
For solid media, granulated agar was added for solidification at a final 
concentration of 2% (w/v) prior to autoclaving. Solid media were prepared by 






2.2.1 Yeast media for the culture of Saccharomyces cerevisiae 
 
Table 2.2. Yeast growth media used in this study 
Media Recipe 
YEPD (Yeast extract, 
peptone, dextrose) 
complete medium 
2 % (w/v) glucose, 1 % (w/v) yeast extract, 2 % (w/v) 
bactopeptone 
¼ YEPD (Yeast extract, 
peptone, dextrose) 
complete medium 
2 % (w/v) glucose, 0.25 % (w/v) yeast extract, 2 % (w/v) 
bactopeptone 
SC (Synthetic complete) 
2% glucose drop-out 
medium 
2 % (w/v) glucose, 0.67 % Yeast Nitrogen Base (without 
amino acids, with ammonium sulphate), the appropriate 
concentration of yeast synthetic complete drop-out media 
supplement 
SC (Synthetic complete)  
2% raffinose drop-out 
medium 
2 % (w/v) Raffinose, the appropriate concentration of yeast 
synthetic complete drop-out media supplement 
SC (Synthetic complete)  
2% galactose and 1 % 
raffinose drop-out medium 
2 % (w/v) Galactose, 1 % Raffinose, the appropriate 
concentration of yeast synthetic complete drop-out media 
supplement 
SC (Synthetic complete)  
2% galactose drop-out 
medium 
2 % (w/v) galactose, 0.67 % Yeast Nitrogen Base (without 
amino acids, with ammonium sulphate), the appropriate 




2.2.2 Growth media for culturing Escherichia coli 
 
Table 2.3. Bacterial growth media used in this study 
Media Recipe 
LB (Luria Bertani) 
medium 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) sodium 
chloride 
NZY+ Broth 1% (w/v) NZ amine (casein hydrolysate), 0.5% (w/v) yeast 
extract, 0.5% (w/v) sodium chloride, adjust to pH 7.5 using 
sodium hydroxide and then autoclave 
Add the following filer-sterilized supplements prior to use: 
1.25% (w/v) 1 M magnesium chloride, 1.25% (w/v) 1 M 
magnesium sulfate, 1% (w/v) 2 M glucose 
 
Ampicillin was used to select for E.coli cells transformed with plasmids 
containing the AmpR gene. Filter-sterilized ampicillin was added to the LB 
medium at a final concentration of 100 µg/ml from a 100 mg/ml stock solution 








All Saccharomyces cerevisiae strains (Table 2.4) were grown in 50 ml Falcon 
tubes or 250 ml conical flasks containing appropriate media at 30°C incubator 
with shaking at 200rpm or on solid media in 30°C incubator. All strains were 
kept as glycerol stocks and stored at -80°C freezer.  
 
 
2.3.1 Saccharomyces cerevisiae strains 
 
Table 2.4. Saccharomyces cerevisiae strains used in this study 
Strain Notes Genotype References 
74D-694 [pin-] MATa ade1-14(UGA) 
trp1-289(UAG) ura3-52 
his3-¨200 leu2-3, 112 
Chernoff et al. 1993 
74D-694 Low [PIN+] MATa ade1-14(UGA) 
trp1-289(UAG) ura3-52 
his3-¨OHX-3, 112 
Chernoff et al. 1993 
74D-694 Medium [PIN+] MATa ade1-14(UGA) 
trp1-289(UAG) ura3-52 
his3-¨OHX-3, 112 
Chernoff et al. 1993 
74D-694 High [PIN+] MATa ade1-14(UGA) 
trp1-289(UAG) ura3-52 
his3-¨OHX-3, 112 
Chernoff et al. 1993 
74D-694 Very high [PIN+] MATa ade1-14(UGA) 
trp1-289(UAG) ura3-52 
his3-¨OHX-3, 112 
Chernoff et al. 1993 
BY4741 [pin-] MATa KLVǻOHXǻ
PHWǻXUDǻ 
Zhiyuan Li 




BY4741 RNQ1 deleted MATa KLVǻOHXǻ
PHWǻXUDǻ 
G. L. Staniforth 
BY4741 BNA4 deleted MATa KLVǻOHXǻ
PHWǻXUDǻ 
G. L. Staniforth 
BY4741 UPF1 deleted MATa KLVǻOHXǻ
PHWǻXUDǻ 
G. L. Staniforth 
BY4741 UPF2 deleted MATa KLVǻOHXǻ
PHWǻXUDǻ 
G. L. Staniforth 
BY4741 UPF3 deleted MATa KLVǻOHXǻ
PHWǻXUDǻ 








2.3.2 Escherichia coli strains 
 
All Escherichia coli strains (Table 2.5) were grown in 1.5 ml Eppendorf tubes, 
50 ml Falcon tubes or 250 ml conical flasks containing appropriate media at 
37°C incubator with shaking at 200  rpm or on solid media in 37°C incubator. 
All strains were kept as glycerol stocks and stored at -80°C freezer.  
 
Table 2.5. Escherichia coli strains used in this study 
Strain Genotype Source 
TOP10 F– mcr$ǻmrr-hsdRMS-mcrBC) 
ĭlac=ǻ0ǻlacX74 recA1 araD139 
ǻara leu) 7697 galU galKrpsL 





Tetrdelta- (mcrA)183 delta- (mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F´ proAB 









Table 2.6. Plasmid used in this study 
Plasmid Characteristic Insert 
pYES2 GAL1 P, URA3, ȝ$PSR  none 
pYES2 GAL1 P, URA3, ȝ$PSR RNQ1 
pYES2 GAL1 P, URA3, ȝ$PSR polyQ25 
pYES2 GAL1 P, URA3, ȝ$PSR polyQ103 
pYES2 GAL1 P, URA3, ȝ$PSR RNQ1 deletion 
pYES2 GAL1 P, URA3, ȝ$PSR BNA4 deletion 
pYES2 GAL1 P, URA3, ȝ$PSR UPF1 deletion 
pYES2 GAL1 P, URA3, ȝ$PSR UPF2 deletion 
pYES2 GAL1 P, URA3, ȝ$PSR UPF3 deletion 
P6442 CUP1 P, URA3, CEN6/ARS, Ampr + SUP35 
NM ORF  
none 
pAG426 GAL1 P, URA3, ȝRNQ1 ORF, N-terminal 
GFP tag 
RNQ1-GFP 
pAG415  UPF1 
GAL1P: promoter of the GAL1 gene; CUP1: promoter of the CUP1 gene; 








2.5 Oligonucleotide primers 
 
All oligonucleotide primers were synthesised by Eurofins MWG Operon. The 
SULPHUVZHUHGLOXWHGDWDILQDOFRQFHQWUDWLRQRISPROȝOLQDQDSSURSULDWH
amount of steriled ultrapure water produced by Direct-Q® 3 Ultrapure Water 
System (Merck Millipore) and stored at -20°C.  
 
Table 2.7. Oligonucleotide primers used for Site-directed mutagenesis 
Primer’s name Sequence (5’-3’) Target 
gene 
His94Arg_F CGGTACAAGCAGCTCCCGCATTGTTAATCACTTAGT UPF1 
His94Arg_R ACTAAGTGATTAACAATGCGGGAGCTGCTTGTACCG UPF1 
Lys436Ala_F GGCCCACCAGGCACTGGTGCAACAGTTACTTCAGCAAC UPF1 
Lys436Ala_R GTTGCTGAAGTAACTGTTGCACCAGTGCCTGGTGGGCC UPF1 
 
Table2.8. Oligonucleotide primers used for verification of Site-directed 
mutagenesis 
Primer’s name Sequence (5’-3’) Target gene 
UPF1_His94_F CAATTCATGTGCGTATTG UPF1 
UPF1_His94_R CACGTTCTTACGTCCAC UPF1 
UPF1_K436A _F GATGTCCCATTACCT UPF1 
UPF1_K436A _R AACCCAAGTCACGTA UPF1 
 
 
2.6 DNA methods 
 
 
2.6.1 Purification of plasmid DNA from Escherichia coli 
 
QIAprep Spin Miniprep Kit (50) (QIAGEN, Cat. no. 27104) was used to purify 
all plasmid DNA. The procedure was carried out as detailed in the 









2.6.2 Agarose gel electrophoresis 
 
0.5 g of agarose was added into a 250 ml conical flask containing 49 ml of 
deionised water and 1 ml of 50 × TAE buffer (40 mM tris, 1 mM EDTA, 20 mM 
acetic acid, pH 8.5). The mixture was placed in a microwave oven for 1 min at 
full power until the agarose was completely dissolved in the buffer. The boiled 
agarose solution was allowed to cool down for 10 min. Then 5 µl of SYBR-
Safe DNA stain (Invitrogen, S33102) was added to the solution. The gel 
solution was slowly poured into a gel tray with the appropriate comb in place. 
20-30 min was allowed for the gel to solidify at room temperature. 500 ml of 1 
× TAE buffer was poured in an electrophoresis tank. 2 µl of 6x blue/orange 
loading buffer (Promega) was added to 10 µl of each DNA sample before 
loading onto the gel. The agarose gel was run at 100 volts for 30-40 mins. 
The DNA fragments were visualised using either a UV transilluminator with 
safety glasses or using FLA-5100 imaging system (FujiFilm). 
 
 
2.6.3 Restriction enzyme digestion 
 
Plasmid DNA was digested by restriction endonucleases in buffers provided 
by the enzyme manufactures (Promega, Roche or New England Biolabs). The 
restriction digest reagent mixture was made of restriction endonucleases (1 µl 
each), appropriate buffer (2 µl), Bovine Serum Albumin (2 µl at a final 
concentration of 2 µg/µl), plasmid DNA (1.5 µl at a final concentration of 1-1.5 
µg/µl) and sterile ultrapure water to a final volume of 20 µl.  For double 
digestions, an appropriate buffer was chosen by web-based restriction 
enzyme assistant software provided by the manufacturer’s website (e.g. 
https://www.neb.com/tools-and-resources/interactive-tools/double-digest-
finder ). The reaction mixture was incubated at 37°C for 3 hours. The result of 








2.6.4 Determination of DNA concentration 
 
DNA concentration was obtained by adding 1 µl of DNA to 99 µl of distilled 
H2O (dH2O). DNA samples were mixed by pipetting in a 1.5 ml Eppendorf and 
transferred to a single sealed cuvette (10 ×2 × 36 mm). The DNA sample was 
loaded in the centre of the measuring area and step were taken to ensure that 
there were no air bubbles. A blank of dH2O was used as a reference. DNA 
concentration was measured at 230, 260 and 280 nm using an BioPhotometer 
plus (Eppendorf)  at a path-length of 1 cm. RNA and protein contaminations 
were determined by a comparison of the 260 nm absorbance divided by the 
280 nm absorbance, while organic compounds or chaotropic salts 
contaminations were determined by the absorbance at 260 nm divided by the 
absorbance at 230 nm. These values are used to verify the purity of DNA 
samples. Typically, DNA samples in good-quality have an A260/A280 ratio of 
1.7- 2.0 and an A260/A230 ratio greater than 1.5 (Promega). 
 
 
2.6.5 QuikChange Lightning Site-Directed Mutagenesis 
 
Mutations in the UPF1 gene were created using a QuickChange Lightning 
Site-Directed Mutagenesis kit (Agilent technologies, Cat. no. 210518). 
Mutagenic primer design was carried out using the QuickChange Primer 
Design Program at www.agilent.com/genomics/qcpd. The oligonucleotides 
used are listed in Table 1.7.  Mutant strand synthesis reaction, restriction 
enzyme digestion and transformation of XL10-Gold ultracompetent cells were 
performed according to the instruction manual (pp 7-11)  
 
 
2.6.6 DNA sequencing 
 
All DNA sequencing in this project was performed by Source BioScience (1 
Orchard Place, Nottingham Business Park, Nottingham, NG8 6PX) using 





final concentration of 100 ng/µl with a total volume of 10 µl. Associated  
primers of each plasmid DNA sample were diluted with sterile ultrapure water 
at a final concentration of 60-70 ng/µl with a total volume of 10 µl for each 
reaction. An online order for DNA sequencing was submitted via the website 
http://www.lifesciences.sourcebioscience.com/ and both purified plasmid DNA 
samples and their corresponding primers were sent directly to Source 
Bioscience. The results of DNA sequencing were received by e-mail and 
analysed using Multiple Sequence Alignment 




2.7 Recombinant DNA methods 
 
 
2.7.1 Preparation of competent E. coli cells 
 
A single colony was picked from an LB plate and transferred into 10 ml of LB 
broth in a 50 ml Falcon tube. The bacterial culture was placed in a 37°C 
incubator with shaking at 220 rpm and grown for 12-16 hrs. 32 µl of saturated 
overnight culture was transferred into 112 ml of LB broth in a 250 ml of conical 
flask and incubated at 37°C with shaking at 220 rpm until OD 600 of 0.5 was 
reached (usually 4 hours). 15 ml of glycerol was heated in a microwave then 
placed in a 37°C water bath. Then 15 ml of sterilized warm glycerol was 
slowly added into the bacterial culture when OD600 was approximately 
reaching 0.5. The culture was placed on ice for 10 mins then transferred into a 
pre-chilled 500 ml centrifuge tube. Cultures were centrifuged at 4000 rpm for 
10 mins at 4°C. The supernatant was carefully discarded by pouring and 
pipetting while the cell pellet was re-suspended in an equal volume of ice-cold 
0.1M MgCl2 with 15% (v/v) sterile glycerol pipetting up and down to gently mix. 
Cells were centrifuged at 3800 rpm for 8 mins at 4°C. The supernatant was 
removed then cells were resuspended in 25 ml of ice-cold T-salts (0.075 M 





ml Falcon tube. Cells were incubated on ice for 20 mins with occasional 
mixing by flicking the bottom of the falcon tube gently. After 20 mins, cells 
were centrifuged at 3600 rpm for 6 mins at 4°C. Finally, the cell pellet was 
resuspended in 5 ml of ice-cold T-salts then transferred into fifty pre-chilled 
1.5 ml Eppendorf tubes as 100 µl aliquots. Aliquoted cells were stored 
immediately at -80°C freezer until required.  
 
 
2.7.2 Transformation of plasmid DNA into Escherichia coli 
 
An aliquot of competent cells was thawed on ice and mixed by flicking the 
tube gently when it had thawed. 2 µl (200-300 ng/µl) of plasmid was added to 
50 µl of competent cells in 1.5 ml Eppendorf tube and was placed on ice for 
30 mins. The Eppendorf tube with the cells was put in a 42°C water bath for 
45 seconds then the tube placed on ice immediately for 2 mins. The cells 
were then re-suspended in 800 µl of LB broth and incubated at 37°C with 
shaking (180 rpm) for one hour. 120 µl of the transformation mixture was 
plated out onto appropriate agar plates containing the appropriate antibiotics 
according to the selective marker on the plasmid. The plates were then placed 
upside down in the 37°C incubator overnight.  
 
 
2.7.3 Transformation of plasmid DNA into Saccharomyces cerevisiae 
 
Yeast cells were harvested by centrifugation at 13000 rpm for 20 seconds at 
room temperature from 2 ml of overnight yeast culture. The supernatant was 
discarded and the cell pellet was resuspended in 82.5 µl of transformation 
solution which was composed of 36 µl of 1 M lithium acetate, 10 µl of freshly 
denatured single-stranded carrier DNA (salmon sperm DNA, 10 mg/ml), 2.5 µl 
RI ȕ- mercaptoethanol and 34 µl of sterile deionised H2O. Then 240 µl of 
polyethylene glycol (PEG)-3350 (50 % w/v) and 3 µl (200-300 ng/µl) of 
plasmid DNA were added to the transformation mixture. Cells were 





transformation mixture was then incubated at 30°C incubator for 30 mins 
followed by heat shock of 42°C for a further 30 mins. Cells were harvested by 
centrifugation at 2000 rpm for 5 mins. The supernatant was discarded and the 
cell pellet resuspended in 150 µl of sterile ultrapure water. Cells were plated 
onto appropriate agar plates that allowed for selection of transformed cell (e.g. 
SC-ura plate for plasmid carrying the URA3 marker). The plates were then 
placed upside down in the 30°C incubator for 3 -4 days. 
 
 
2.8 Growth conditions and analysis 
 
 
2.8.1 Determination of cell density 
 
Cell density was obtained by measuring either diluted or undiluted cell culture 
up to 1 ml of corresponding medium into a plastic cuvette. The cell sample 
was mixed by vortexing. A blank of growth medium (i.e. no cells) was used as 
a reference. Cell density was measured at 600 nm using BioPhotometer plus 
(Eppendorf) at a path-length of 1 cm.  
 
 
2.8.2 Cell induction by galactose 
 
Yeast cells were grown overnight in 5 ml of SC (Synthetic complete) 2% 
glucose drop-out medium (Table 2.2) at 30°C incubator with shaking at 200 
rpm. Cells were collected by centrifugation at 3000 rpm for 5 mins at room 
temperature. The supernatant was discarded and cells were washed in sterile 
water three times in order to remove all the glucose containing medium. 5 ml 
of SC (Synthetic complete) 2% galactose drop-out medium (Table 2.2) was 
added for induction. Cells were incubated at 30°C incubator with shaking at 





genes under the control of the plasmid with GAL1 promoter (e.g. pYES2-
based constructs).  
 
 
2.8.3 Growth analysis by microplate reader 
 
A single colony of the required yeast strain was inoculated into a 50ml Falcon 
tube containing 5 ml of appropriate liquid medium as a starter culture. This 
culture was grown overnight at 30°C with shaking at 200 rpm. Cells were then 
diluted to an OD600 of 0.1 with a final volume of 1ml in a 24-well sterile plate 
(Greiner). Growth curves were generated by a Fluostar Omega microplate 
reader according to the reading of OD600 hour by hour (usually use 24 or 36 
hours as a period). 
 
 
2.8.4 Calculation of doubling time 
 
Doubling time is the amount of time it takes for a given quantity to double in 
size or value at a constant growth rate. The doubling time of each strain used 
in this study was determined with the following calculation: time in minutes 
was plotted against OD600 values using MS Excel, an exponential trend-line 
was applied to the graph along with the trend-line equation, the natural 




2.9 Biological assays 
 
 
2.9.1 [PIN+] de novo conversion assay 
 
One [pin-] and four [PIN+] variants ([PIN+]Low, [PIN+]Medium, [PIN+]High and 





p6442 as described in Section 2.4. The plasmid p6442 contains a region of 
expressing Sup35pNM-GFP fusion protein under the CUP1 promoter. A small 
portion of a single transformed colony of each variant was inoculated into 50 
ml of selective medium according to the selective marker on the plasmid in a 
250 ml conical flask for overnight growth at 30°C incubator with shaking at 
200 rpm. The cell number of 1 ml of the overnight culture was calculated by a 
haemocytometer. Cells were diluted in sterile water to a final volume of 100 µl 
which contains approximately 300 cells. Then 100 µl of diluted cells were 
plated onto appropriate agar plate. The plates were placed upside down in the 
in the 30°C incubator for three days. After three days, a single colony was 
randomly selected from each plate containing different [PIN] variants and re-
suspended each colony into a 250 ml conical flask containing 50 ml of 
appropriate selective medium with CuSO4 at a final concentration of 25µM. 
The flask was placed into 30°C incubator with shaking (200 rpm) for  24 hours. 
5 µl of each variant was spotted onto three distinct fresh synthetic complete 
drop-out selection media (1/4 YPD complete medium, SC-ade medium, ¼ 
YPD + 3mM GdnHCl medium). The plates were dried at room temperature 
until the culture was totally absorbed by the agar. The plates were placed 
upside down in a 30°C incubator for 3 -4 days until colonies were grown to an 




2.9.2 Toxicity assay 
 
Expression of the relevant GAL1 promoter-regulated gene was induced by 
galactose as described in section 2.9.2. Cell samples were diluted to an OD600 
of 0.5 into 1 ml of 2% galactose synthetic complete selective repressing 
medium in 1.5 ml Eppendorf. 200 µl of the diluted sample was transferred into 
the first well as the most concentrated culture. 120 µl of 2% galactose 
synthetic complete selective repressing medium was loaded to well 2, 3, 4 
and 5 by a multi-channel pipette. Then 30 µl of the most concentrated culture 





synthetic complete selective repressing medium. This represents a 1:5 
dilution from the concentrated culture. Five consecutive dilutions were carried 
out by transferring 30 µl of concentrated culture to the following well with 120 
µl of 2% galactose synthetic complete selective repressing medium. The 
cumulative dilutions of the sample from the most concentrated culture to the 
least concentrated culture were 1, 1:5, 1:25, 1:125, 1:625 respectively. Cell 
suspensions were mixed thoroughly by pipetting the 30 µl of the culture up 
and down at least 10 times for each dilution step.  4 µl of each dilution was 
spotted onto three different fresh synthetic complete drop-out selection plates 
[¼ YEPD complete medium, SC (Synthetic complete) drop-out medium, SC 
(Synthetic complete) 2 % galactose drop-out medium]. The plates were dried 
at room temperature until the culture was totally absorbed by the agar. The 
plates were placed upside down in a 30°C incubator for 3-4 days until 
colonies were grown to an appropriate size. The plates were scanned under a 
black background for good contrast.  
 
 
2.9.3 Reactive Oxygen Species (ROS) detection using Fluorescence 
Activated Cell Sorting (FACS) 
 
Cells were induced by galactose induction as described in section 2.9.2. 
Samples were diluted with 1 × PBS to an OD600 of 0.5 at a final volume of 1 ml. 
2 µl of dihydroethidium (DHE) dye was added to each sample to a final 
concentration of 10 µM DHE. DHE was used for detecting the production of 
superoxide radicals. Dihydroethidium is fluorescent blue while it turns to 
fluorescent red in its oxidised form (hydroxyethidium) as generated by 
superoxide radicals. Cells were incubated with DHE for 10 mins before 
Reactive Oxygen Species (ROS) detection by a BD FACSCalibur flow 









2.10 Protein methods 
 
 
2.10.1 Preparation of cell extract for quantitative western blot analysis 
 
Cell extract preparation was carried out based on the protocol published by 
von der Haar (2007). A yeast culture was grown in 250 ml of conical flask 
containing appropriate medium until an OD600 of approximately 0.6- 0.8. Eight 
OD600 units of the cell culture in exponential phase of growth were harvested 
by centrifugation at 3000 rpm for 5 min at room temperature. The medium 
was discarded and the cell pellet was washed once with sterile ultrapure 
water. Then the cell pellet was resuspended in 200 µl of quantitative lysis 
buffer (0.1 M NaOH, 0.05 M EDTA,  6'6  ȕ-mercaptoethanol). The 
cell suspension was incubated for 10 min at 90°C followed by the addition of 5 
µl of 4 M acetic acid in order to neutralise NaOH of the lysis buffer and 
vortexing for 30 secs to mix. Then the suspension was incubated at 90°C for a 
further 10 mins. Samples were allowed to cool and 50 µl of loading buffer 
(0.25 M Tris-HCl pH6.8, 50% glycerol, 0.05% bromophenol blue) was added 
to 200 µl of cells extracts. 
 
 
2.10.2 Separation of proteins by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
 
SDS-PAGE gels were prepared with a resolving gel (0.375 M Tris, pH 8.8, 
0.1% SDS, 10% acrylamide, 0.15% ammonium persulphate, 0.07% TEMED) 
and a upper stacking gel (0.25 mM Tris, pH 6.8, 0.1% SDS, 0.23% 
ammonium persulphate, 0.07% TEMED) using a 1 mm cassette (Invitrogen). 
The resolving gel mixture was mixed by swirling and immediately loaded into 
the 1 mm cassette with a pipette filled to approximately 4/5 of the cassette. 
100% ethanol was added on the top of the resolving gel. Once the resolving 
gel was solidified, ethanol was poured off and the cassette was rinsed with 





touching the resolving gel. The stacking gel solution was then mixed and 
pipetted onto the top of the resolving gel. A comb with an appropriate size 
was placed into the stacking gel and then removed once the stacking gel was 
set. The SDS-PAGE gel was run at 150 V for 90 mins with SDS running buffer 
(0.025 M Tris base, 0.188 M Glycine, 0.15% (w/v) SDS) of a X- Cell Surelock 
gel tank (Invitrogen) using either a PS304 (GibcoBRL) or 200/2.0 (Bio-Rad) 
electrophoresis power supply.  
 
 
2.10.3 Coomassie brilliant blue staining and destaining 
 
The SDS-PAGE gel was immersed in Coomassie brilliant blue stain (40 % 
(v/v) Methanol, 20 % (v/v) Glacial acetic acid, 0.1 % (w/v) Coomassie brilliant 
blue R250) and incubated for 30 mins on an obital shaker at room 
temperature. The Coomassie brilliant blue stain was then discarded and 
replaced by destain solution (10 % (v/v) Methanol, 10 % (v/v) Acetic acid). 
The gel was destained against two or three changes of the destain solution at 




2.10.4 Western blotting 
 
A piece of Hybond ECL nitrocellulose blotting membrane (GE healthcare) was 
cut to fit the size of the SDS-PAGE gel (7× 8 cm for Invitrogen pre-cast gels). 
The membrane and the SDS-PAGE gel were transferred to a box containing 
Transfer buffer (20% Methanol, 0.037% SDS, 48 mM Tris base and 38.6 mM 
Glycine) and incubated on a shaker for 15 mins. Two pieces of thick blotting 
paper (Biorad) were cut to the same size as the membrane and soaked in the 
box containing transfer buffer. One piece of the blotting paper was placed in 
the middle of the blotting apparatus and air bubbles were removed using a 
roller with little pressure. The membrane, SDS-PAGE gel and the other piece 
of the blotting paper (from bottom to top) were placed exactly on the top of the 





the roller over the top of the sandwich. The electrophoretic transfer was 




2.10.5 Chemiluminescence detection 
 
The transferred membrane was removed from the blotting apparatus and 
incubated in PBS-M buffer (5% (w/v) milk powder (Marvel), 1 × PBS) for at 
least 10 mins at room temperature with shaking. Primary antibody was diluted 
to an appropriate concentration in 10- 15 ml of PBS-M buffer and incubated at 
4 °C overnight with shaking. The following day, the membrane was washed 
briefly with 20 ml of fresh PBS-M buffer and incubated with the secondary 
antibody solution for 1- 2 hrs at room temperature with shaking. The 
secondary antibody solution was prepared in 10- 15 ml of PBS-M buffer to an 
appropriate concentration. After incubation with the secondary antibody, the 
membrane was washed three times in PBS for 5 mins each with shaking. In 
the dark room, a 1:1 mixture of the following two solutions: ECL solution 1 (2.5 
mM Luminol, 396 ȝ0 &RXPDULF DFLG  0 7ULV-HCl, pH 8.5) and ECL 
solution 2  (0.0192% Hydrogen peroxide, 0.1 M Tris-HCl, pH 8.5) was freshly 
made and incubated with the membrane for 1- 2 mins. The ECL solution 1 
and ECL solution 2 were protected from light with aluminium and mixed only 
before using. The membrane and one piece of Amersham hyperfilm ECL (GE 
Healthcare) were placed in the cassette for a few sec and developed using a 











2.11 Fluorescence microscopy methods 
 
 
2.11.1 GFP microscopy 
 
Log phase cells (OD600 ~ 0.6 to 1) were harvested by centrifugation at 13,000 
rpm for 1 min. The supernatant was discarded and the pellet washed once in 
sterile water. Cells were re-suspended in an appropriate amount of sterile 
water. 3- ȝO RI VDPSOH ZDV SLSHWWHG RQ D JODVV VOLGH FRYHUHG ZLWK WKH
coverslip. One drop of oil was dripped onto the coverslip for protecting lens. 
Cells were visualised by a green excitation filter on an Olympus 1X81 
fluorescent microscope with Hamamatsu Photonics Orca AG cooled CCD 
camera. Images were captured analysed by Olympus CellR software. 
 
 
2.11.2 DAPI staining 
 
1 ml of log-phase cells (OD600 ~ 0.6 to 1) were harvested by centrifugation at 
13,000 rpm for 1 min. The supernatant was discarded, the pellet was fixed in 
70% ethanol for 10 mins and then the cells were washed once in sterile water. 
Cells were re-suspended in appropriate amount of sterile water (typically 30 ȝO
and 4',6-diamidino-2-phenylindole (DAPI) as a fluorescent stain which binds to 
A-T rich regions in both nuclear and mitochondrial DNA was added at a final 
concentration of 1 µg/ml. 3- ȝO RI VDPSOH ZDV VSRWWHG RQ D JODVV VOLGH
covered with the coverslip. One drop of oil was dripped onto the coverslip in 
order to protect the lens. Cells were visualised by a blue excitation filter on an 
Olympus 1X81 fluorescent microscope with Hamamatsu Photonics Orca AG 










2.12 Electron microscopy methods 
 
Yeast cells were grown and induced by galactose as described in Section 
2.8.2. An equivalent of 10 OD600 units of log phase cells was harvested by 
centrifugation at 3000 rpm for 5 min at 4°C a t two time points (t=0 and t=6). 
Two volumes of 2 × fixative (5% glutaraldehyde in PBS) were then added to 
each culture, thoroughly mixed and harvested by centrifugation at 3000 rpm 
for 5 min at 4°C. The supernatant was discarded and the cell pellet was 
resuspended in one volume of 1× fixative (2.5% glutaraldehyde in PBS) and 
kept as cell suspension at 4°C overnight. On the following day, cells were 
pelleted by centrifugation at 3000 rpm for 5 min at 4°C.  All further steps 
involving osmium tetroxide fixation, dehydration, embedding, thin section and 
positive staining were performed by Ian Brown a Microscopy Suite Facility 
Manager of the University of Kent. Images were acquired on a JEOL JEM-
1230 transmission electron microscope (80 kV; Jeol) with a Gatan Orius 


























Chapter 3  
 
De novo formation of [PSI+] prion detected 






















The de novo formation of the [PSI+] prion occurs either spontaneously or can 
be induced by the overexpression of Sup35NM domain or full-length Sup35 
(Chernoff et al., 1993; Derkatch et al., 1996). The spontaneous de novo 
conversion of Sup35 into [PSI+] arises at a very low rate, approximately 5 x10-
7
 (Lund et al., 1981; Lancaster et al., 2010). The spontaneous and induced de 
novo formation of [PSI+] is facilitated by other prions. Evidence suggests that 
the presence of [PIN+] (Derkatch et al., 1997), [URE3] (Derkatch et al., 2001), 
[SWI+] (Du et al., 2014) and aggregating variants of huntingtin (Derkatch et al., 
2004) can enhance the de novo appearance of the [PSI+] prion. 
 
Similar to the mammalian prion, PrPSc, which has different variants generating 
distinct symptoms of transmissible spongiform encephalopathies (Bruce., 
1993), [PSI+] can exist in the form of different types of aggregates known as 
variants. These variants have an unaltered genotype but show different 
strengths of the [PSI+]-associated nonsense suppression phenotype 
(Derkatch et al., 1996; Derkatch et al., 1997; Zhou et al., 2001). There are 
mainly two types of [PSI+] variants: strong [PSI+] and weak [PSI+] variants. 
The strong [PSI+] ade1-14 variant forms white Ade+ colonies while the weak 
[PSI+] variant forms red/pink colonies on rich medium and poor growth on 
adenine deficient medium. This is because ade1-14 nonsense suppression is 
more efficient in a strong [PSI+] variant than a weak [PSI+] variant. In addition, 
the activity of molecular chaperones has been found to affect prion variants. 
For example, Hsp70 activity is affected by either over- or under-expression of 
SSE1 that results in a specific [PSI+] variant when induced (Fan et al., 2007) 
Evidence suggests that Sse1 acts as a nucleotide exchange factor for Hsp70 
members, in this case, Ssa1 and Ssb1 (Dragovic et al., 2006). Sse1 promotes 
the de novo formation of [PSI+] mainly based on Ssa1 function. It was 
established that overexpression of Sse1 can more efficiently stimulate the 
function of Ssa1 indicating that Sse1 interacts preferentially with Ssa1. 
Interaction between Sse1 and Ssa1 plays a key role in establishing the full 





eliminated by either overexpression of Hsp104 or growth in the presence of 
millimolar concentrations of guanidine hydrochloride (GdnHCl) (Tuite et al., 
1981). GdnHCl treatment results in the inhibition of the replication of the [PSI+] 
seeds thus impeding [PSI+] propagation. The Hsp104 chaperone is crucial for 
the propagation of the [PSI+] prion and the ATPase activity of Hsp104 can be 
inhibited by GdnHCl at low concentration thus blocking [PSI+] propagation 
(Eaglestone et al., 2000; Ferreira et al., 2001). 
 
For the various [PSI+] variants, the efficiency of translation termination 
corresponds to the level of soluble Sup35, whereas the phenotype of [PIN+] 
variants do not correspond to levels of soluble Rnq1 (Bradley et al., 2002). 
The nomenclature of [PIN+] variants is based on the relative strength of the de 
novo formation of [PSI+] seen in strains carrying the [PIN+] variants. Using de 
novo [PSI+] formation by Sup35 overexpression, five different [PIN] variants 
were identified according to the frequency of the de novo formation of [PSI+]. 
The variants were identified as [pin-], low [PIN+], medium [PIN+], high [PIN+] 
and very high [PIN+] (Derkatch et al., 1997). 
 
Each [PIN+] variant has a distinct phenotype that differs in the efficiency of 
[PSI+] induction (Bradley et al., 2002), the morphology of Rnq1-GFP 
aggregates (Bradley et al., 2003), the stability of Rnq1 aggregates (Bradley et 
al., 2002; Liebman et al., 2006), and the degree of variant dominance 
(Bradley et al., 2002). These distinct phenotypes make [PIN+] a potent 
candidate to further investigate the property of prion variants not least 
because the Rnq1 protein has no known function other than the gain of 
function seen in de novo prion formation. In this chapter, [pin-] and four 










3.2 [PIN+] variants show different frequencies of de novo formation of 
[PSI+] 
 
The best characterised phenotype associated with the [PIN+] prion is the 
enhancement of the de novo formation of [PSI+]. A nonsense suppression 
assay (Section 2.9.1) was initially used to confirm whether the different [PIN+] 
variants had the expected differences in frequency of de novo appearance of 
[PSI+]. In brief, the de novo formation of [PSI+] was achieved by 
overexpressing a Sup35NM-GFP fusion protein under the control of a CUP1 
promoter and monitoring the appearance of [PSI+] colonies following induction 
with 25µM of CuSO4.  
 
A [pin-] derivate and four different [PIN+] variants of 74D-694 were each 
transformed with the p6442 plasmid which is a copper-driven expression 
vector. Cells of each variant were grown in 2% glucose-ade medium with 
CuSO4 at a final concentration of 25 µM for 24 hours at 30°C. 5 µl of cells  
were then spotted on to SC-ade + 1% YEPD plates, ¼ YEPD plate and ¼ 
YEPD plates supplemented with 3 mM GdnHCl. The appearance of colonies 
and colony colour were compared. Only [PSI+] strains could grow on the SC-
ade + 1% YEPD plates since the nonsense mutant ade1-14 was suppressed 
resulting in synthesis of adenine. The [psi-] strain is not able to synthesize 
adenine due to production of a truncated Ade1 protein in the adenine 
synthesis pathway and hence the Ade- phenotype (Chernoff et al., 1995). The 
¼ YEPD plates supplemented with 3 mM GdnHCl served as an additional 
control. If the white or pink colonies on the ¼ YEPD plates reverted to red 
colonies on GdnHCl supplemented plates, this confirms that this strain is 
[PSI+]. Cells growth on the selective medium (SC-ade + 1% YEPD plate) is 
indicative of positive complementation. The ¼ YEPD plate as a non-selective 
medium which contains adenine is used as a control. The ¼ YEPD plate 
supplemented with 3 mM GdnHCl is used as another control for assessing the 






The highest efficiency of [PSI+] de novo formation was found in very high 
[PIN+] variant while the [pin-] strain showed only two Ade+ colonies that might 
be due to the spontaneous de novo formation of [PSI+] (Figure 3.1).  
 
 
Figure 3.1 The efficiency of de novo formation of [PSI+] differs in different [PIN+] 
variants of the strain 74D-694. The highest efficiency of [PSI+] de novo formation 
was observed in very high [PIN+] variant.  
 
 
3.3 The spectrum of [PSI+] variants that arises de novo is influenced by 
the [PIN+] variants 
 
As described in Section 3.2, the [PIN+] de novo conversion assay showed that 
the efficiency of de novo appearance of [PSI+] differed in different [PIN+] 
variants. To further test whether different [PIN+] variants gave rise to different 
types of [PSI+] variants, 40 colonies of each [PIN+] variant were randomly 
selected and spotted onto three different solid media. SC-ade + 1% YEPD 
plates showed the de novo appearance of the [PSI+] prion. Strong [PSI+] 
variants form white colonies while weak [PSI+] give rise to pink colonies 
(Figure 3.2 a). ¼ YEPD plates were used as a spotting control for monitoring 
general growth defects that might not be associated with the de novo 
appearance of the [PSI+] prion. ¼ YEPD + 3mMGdnHCl plates served as an 
additional control for confirming whether the de novo formed colony is a [PSI+]. 





which forms red colonies (Tuite et al., 1981). If a colony remains white or pink 
on GdnHCl supplemented plates, it can be concluded that the candidate cell 
has a nuclear suppressor mutation (Lund et al., 1981; Lancaster et al., 2010). 
The results revealed different [PIN+] variants are capable of generating both 







SC-ade + 1% YEPD ¼ YEPD ¼ YEPD + 3mMGdnHCl 



















Figure 3.2 [PIN+] variants can generate both strong [PSI+] and weak [PSI+]. (a) 
Illustration of [psi-], strong [PSI+] and weak [PSI+] phenotype.  (b) Different [PIN+] 





3.4 Quantitative analysis of the de novo formation of strong [PSI+] and 
weak [PSI+] in strains carrying different [PIN+] variants 
 
 
Since the different [PIN+] variants gave rise to both strong [PSI+] and weak 
[PSI+], it was next of interest to determine the effects of different [PIN+] 
variants on the efficiency of de novo formation of strong [PSI+] and weak 
[PSI+]. 40 [PSI+] colonies were selected for each strain. The total number of 
Ade+ colonies was counted from the adenine drop-out medium, YEPD 
supplemented (SC-Ade + 1% YEPD) medium as a baseline. The number of 
non-[PSI+] colonies was obtained by a comparison of the corresponding 
colonies on the SC-Ade + 1% YEPD medium and ¼ YEPD medium 
supplemented with 3 mM GdnHCl. If the corresponding colony was red on the 
medium containing 3mM GdnHCl, it could be confirmed as a [PSI+]. White 
colonies on the SC-Ade + 1% YEPD plates were counted as strong [PSI+] 
variant while pink colonies were recorded as weak [PSI+] variant (Table 3.1).  
 
As expected, the [pin-] strain cannot generate any [PSI+] variant. All four [PIN+] 
variants can generate different [PSI+]. The low [PIN+] variant shows the 
highest frequency of nuclear mutation. The low and medium [PIN+] variants 
preferentially gave rise to weak [PSI+] variant. Interestingly, the high [PIN+] 
variant shows the highest frequency of strong [PSI+] formation while the very 
high [PIN+] variant shows the highest frequency of weak [PSI+] formation. This 
suggests that different [PIN+] variants may underlie different pathways on the 











Table 3.1 Quantitative analysis of the de novo formation of strong [PSI+] and 
weak [PSI+] depending on different [PIN+] variants. 
 















[pin-] 38 0 0 38 (100%) 
[PIN+]LOW 29 10 (34%) 7 (24%) 12 (41%) 
[PIN+]MED 35 19 (54%) 16 (46%) 0  
[PIN+]HIGH 39 27 (69%) 7(18%) 5 (13%) 
[PIN+]VERY H. 38 13 (34%) 24 (63%) 1 (3%) 
These data indicate that [pin-] cannot form [PSI+]. [PIN+]LOW shows the lowest 
frequency of [PSI+] formation. All four [PIN+] variants can generate different [PSI+] i.e 
strong [PSI+], weak [PSI+]. 
 
[PSI+] were defined by the loss of the Ade phenotype when grown on a medium 
containing 3mM GdnHCl;  
* % of total in bracket 
 
 
3.5 Levels of the Rnq1 protein in different [PIN+] variants 
 
As described in Section 3.2, the efficiency of [PSI+] de novo formation was 
different in the four [PIN+] variants. It was important to further investigate 
whether the levels of the Rnq1 protein have an impact on the efficiency of 
[PSI+] de novo formation. This was tested by western blot (Section 2.10.4). 
Since the testing protein Rnq1 and the loading control protein PGK have 
similar molecular weights (43kDa and 47kDa respectively), the two proteins 
were loaded on two separate gels and detected with either anti-Rnq1 or anti-
PGK antibody (Figure 3.3).  
 
The first attempt of the western blot was to load both Rnq1 and PGK on the 
10% gel. However, the bands of Rnq1 and PGK were stacked up due to their 
similar molecular weight. The second attempt was to use 12% gel aiming at 
separating the bands of Rnq1 and PGK proteins. However, this failed to show 
the band clearly. Then 15% gel was used to further separate the two proteins 





and the loading control protein PGK were loaded on separate 10% gels and 
put into one picture by ‘paint’ software as shown in Figure 3.3. 
 
The result showed that the high and very high [PIN+] variants contain more 
Rnq1 than the low and medium [PIN+] variants, as compared to the loading 
control which was used to confirm that the Rnq1 protein had been evenly 
loaded. However, no Rnq1 was seen in the [pin-] variant, which might be due 
to soluble Rnq1 being unstable (G. L. Staniforth, personal communication). 
The low and medium [PIN+] variants may be slightly susceptible to 
degradation while the high and very high [PIN+] variants are much more 
robust. This result was consistent with the [PIN+] de novo conversion assay i.e. 
higher efficiency of [PSI+] de novo formation was found in the high and very 
high [PIN+] variants, while lower efficiency of [PSI+] de novo formation was 
found in the low and medium [PIN+] variants. This result suggests that the 



















The [PIN+] de novo conversion assay confirmed that [pin-] cannot form [PSI+] 
de novo while four [PIN+] variants (low [PIN+], medium [PIN+], high [PIN+] and 
very high [PIN+]) gave rise to two different types of [PSI+] variant: weak [PSI+] 
and strong [PSI+]. This same result ie. that different [PIN+] variants can  
generate different [PSI+] variants, was very recently published by Sharma and 
Liebman (2013). The very high [PIN+] variant showed the highest efficiency on 
the de novo formation of [PSI+] whereas the low [PIN+] variant showed the 
lowest frequency of the de novo appearance of [PSI+]. There was also a 
difference between the percentage of de novo formed weak [PSI+] and strong 
[PSI+] variants depending on the type of different [PIN+] variant. 
 
As far as we know, determination of [PSI+] variants is based on the level of 
soluble cellular Sup35 in the strain i.e. the weak [PSI+] variant has more 
soluble Sup35 protein than the strong [PSI+]. The [PIN+] variant was first 
distinguished by the efficiency of the de novo formation of [PSI+] when Sup35 
was overexpressed. Like [PSI+] variants, the [PIN+] variant has different 
amount of soluble Rnq1 protein, but this does not influence the efficiency of 
the different [PSI+] formation. Thus it is interesting to investigate what is the 
possible factor that regulates the de novo formation of different [PSI+] variants 
depending on different [PIN+] variants. 
 
One possible reason is that each [PIN+] variant with its distinct steric structure 
can act as a prion seed during the formation of [PSI+] variants. The distinct 
conformation of different [PIN+] variants may be able to facilitate the formation 
of [PSI+] variants at different rate thereby preferentially producing a particular 
variant of [PSI+]. Moreover, it was established that the binding of Sup35 to 
different [PIN+] variants happens with the same efficiency while the conversion 
of Sup35 to the particular aggregated form is the key step during the process 






Since the strong [PSI+] variant has more prion seeds than the weak [PSI+] 
variant (Derdowski et al., 2010), another possible reason for different [PIN+] 
variants generating different [PSI+] variant is that the [PIN+] variant may affect 













Chapter 4  
 























Elevated protein levels, for example, overexpression of Rnq1, can have an 
impact on protein homeostasis which in turn can lead to amyloid formation. As 
far as we know, the appearance of amyloid deposits is associated with a 
number of protein misfolding diseases. However, the specific correlation 
between the pathogenicity of neurodegenerative diseases and amyloid 
formation still remains poorly understood. In general, almost any misfolded 
protein is able to generate some level of toxicity or cause cellular dysfunctions 
(Stefani and Dobson, 2003). 
 
In the yeast Saccharomyces cerevisiae, the Rnq1 protein can exist in its 
soluble state as a monomer or an aggregated infectious state known as the 
[PIN+] prion. The only known biological function of Rnq1 is that it enhances 
the conversion of other prion proteins from their normal states to their prion 
states when  itself is in the prion form, i.e. [PIN+] (Derkatch et al., 2001 and 
Osherovich et al., 2001). Since the cellular function of Rnq1 is poorly 
understood, little information is known about how it might differentially impact 
on the cell in its normal ([pin-]) and prion ([PIN+]) states.  
 
A previous study revealed that overexpression of Rnq1 is toxic to cells if the 
endogenous Rnq1 protein is in its prion form ([PIN+]), whereas it is not toxic to 
cells when the endogenous Rnq1 is in its soluble form i.e. [pin-] (Douglas et al., 
2008). This [PIN+]-dependent toxicity of Rnq1 can be suppressed by 
overexpression of Sis1, a molecular chaperone from the Hsp40 family 
(Douglas et al., 2008). In addition, eight other genes had been found that 
when overexpressed suppress Rnq1 toxicity: GPG1, HRR25, MSA1, NVJ1, 
SPC29, THI2 and YNL208w. In [PIN+] cells, Rnq1 overexpression triggers a 
spindle checkpoint leading to a cell cycle arrest in mitosis as duplication of 
spindle pole body is affected by the overexpression of Rnq1 (Treusch and 
Lindquist, 2012). Evidence suggests that there is an accumulation of large-
budded cells when Rnq1 is overexpressed in a [PIN+] background. This 





replicated DNA content was found in these cells that had not undergone 
mitosis. Thus the cell cycle arrest can be triggered by the spindle checkpoint 
or DNA damage checkpoint (Treusch and Lindquist, 2012).  
 
In this chapter, a combination of cell biological and genetic approaches such 
as comparative toxicity assays, growth assays, determination of the levels 
reactive oxygen species (ROS) and microscopy were used to further 
investigate the impact of Rnq1 overexpression in [PIN+] cells in order to better 
understand the mechanism of Rnq1 overexpression-induced cytotoxicity in 
different [PIN+] variants. 
 
 
4.2 Rnq1 overexpression is toxic in different [PIN+] variants but not in a 
[pin-] background   
 
Since Rnq1 overexpression is known to be toxic in [PIN+] cells, but not in [pin-] 
cells (Douglas et al., 2008), it was of interest to further examine the toxicity 
phenotype in different [PIN+] variants when Rnq1 was overexpressed. As 
discussed in Chapter 3, different [PIN+] variants show different frequencies of 
de novo formation of [PSI+] and the hypothesis to be tested was that different 
[PIN+] variants would also give rise to different degree of toxicity when Rnq1 
was overexpressed, linking the two processes i.e. de novo formation of prions 
and amyloid-associated toxicity, at least mechanistically. 
 
In order to test this hypothesis, the galactose-inducible promoter GAL1 was 
used to overexpress the RNQ1 gene in the S. cerevisiae strain 74D-694. A 
[pin-] derivative and four different [PIN+] derivatives of 74D-694 i.e. low [PIN+], 
medium [PIN+], high [PIN+] and very high [PIN+] (Derkatch et al., 1997) were 
each transformed with either the pYES2 (control) or the pYES2-RNQ1 
plasmids. Strains harbouring pYES2 or pYES2-RNQ1 were grown overnight 
in a synthetic dropout medium (SC-ura) containing 2% glucose. The overnight 
cultures were washed three times in order to remove all glucose-containing 





(SC-ura) containing 2% galactose. Cells were incubated for 8 hours in this 
inducing medium and then Rnq1 overexpression induced cytotoxicity was 
determined by spotting 5-fold serial dilutions of the cells of each yeast sample 
(i.e. 74D-694 based four different [PIN+] strains and [pin-] strain) onto the 
surface of different agar plates. Glucose-ura agar plates were used as 
controls since there would be no elevation of Rnq1 levels in cells grown on 
this medium. ¼ YEPD agar plates served as an additional control to monitor 
general growth defects that may not be associated with the overexpression of 
Rnq1 proteins. 2% Galactose-ura agar plates were used to evaluate the 
growth defects of [PIN+] cells overexpressing Rnq1 using the protocol 
illustrated in Figure 4.1. 
 
Figure 4.1 Illustration of Rnq1-induced toxicity assay. General overview of the 
toxicity assays performed in this study. 
 
 
As previously reported (Douglas et al., 2008), Rnq1 overexpression was not 
toxic in a [pin-] background whereas it was toxic in all four different [PIN+] 
variants. Moreover, the degree of toxicity also differed between the different 
[PIN+] variants. For example, overexpression of Rnq1 was less toxic in low 


















Figure 4.2 Overexpression of Rnq1 results in different degrees of cytotoxicity 
in different [PIN+] variants of 74D-694 cells. (a) Rnq1 overexpression was not toxic 
in [pin-] variant. (b) (c) (d) (e) Rnq1 overexpression was toxic in all four [PIN+] 
variants as indicated. pYES2 is the control plasmid while pYES2-RNQ1 is the pYES2 
vector carrying the RNQ1 gene. Three biological replicates were performed for each 
strain and one representative is shown for each.  
 
strains (Figure 4.2). This result was also supported by the findings reported in 
Chapter 3, namely that different [PIN+] variants showed different frequencies 
of de novo formation of [PSI+] i.e. the low [PIN+] variant showed the lowest 
frequency of the de novo formation of [PSI+] while very high [PIN+] variant 
showed the highest frequency of the de novo formation of [PSI+]. These 





may be similar to that leads to cytotoxicity. Therefore, increased frequency of 
the de novo formation of [PSI+] by different [PIN+] variants correlates to 
increased cytotoxicity when Rnq1 was overexpressed. 
 
Rnq1 overexpression-induced cytotoxicity was also determined in another 
Saccharomyces cerevisiae strain BY4741. The BY4741 strain is [PIN+] 
(G.L.Staniforth, personal communication) but has a very different genetic 
origin to 74D-694 and hence was used to control for any non-specified effects 
of genetic background on amyloid-induced toxicity. In addition, BY4741 is a 
haploid derivative of strain S288C while 74D-694 is a Russian strain of 
unknown origin (M. F. Tuite, personal communication). The generation of a 
[pin-] derivative of BY4741 was achieved by sequential passage of cells on 
YEPD plates containing 3 mM guanidine hydrochloride (GdnHCl) as this 
eliminates [PIN+] (Sondheimer and Lindquist 2000). Toxicity assays showed 
that Rnq1 overexpression was toxic in [PIN+] cells but not [pin-] cells of 
BY4741 (Figure 4.3). Thus, the same outcome of Rnq1 overexpression-
induced cytotoxicity was seen in yeast strain BY4741 indicating that there was 





























Figure 4.3 Overexpression of Rnq1 also resulted in [PIN+]-dependent 
cytotoxicity in BY4741 cells. Rnq1 overexpression was not toxic in [pin-] but toxic in 
[PIN+] strains. pYES2 is the control plasmid while RNQ1 is the pYES2 vector with 
RNQ1 insert. Three biological replicates were performed for each strain and one 





4.3 Rnq1 overexpression causes a growth defect in [PIN+] cells 
 
 
In order to confirm the results obtained from toxicity assays, growth assays 
were carried out to quantify the impact of Rnq1 overexpression on the growth 
rate of both [pin-] and [PIN+] 74D-694 strains. Cells were grown under the 
same conditions as the toxicity assays (see Section 2.8.3)  and after washing 
off all the glucose-containing medium, cells were grown in the selective, 
inducing medium i.e. SD 2% galactose for 48 hours at 30°C. Readings of 
OD600 were recorded every hour using a Fluostar Omega microplate reader. 
The results of growth analysis confirm that Rnq1 overexpression does not 
cause a growth defect in [pin-] cells but does lead to growth defects in all four 
[PIN+] strains (Figure 4.4). The doubling time of the [pin-] strain expressing the 
pYES2 plasmid or Rnq1 was similar. In the low and medium [PIN+] strains 
overexpressing Rnq1, the doubling time was about 25 hours compared to 20 
hours in the corresponding [PIN+] strains expressing the pYES2 plasmid. 
While in the high and very high [PIN+] strains overexpressing Rnq1, the 
doubling time was increased to approximately 33 hours (Table 4.1). The 
longer doubling time confirmed that Rnq1 overexpression was more toxic in 
the high and very high [PIN+] strains compared with the low and medium [PIN+] 
strains.  
 
Table 4.1 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of 74D-
694 and BY4741 
 
Strain Plasmid Doubling time (hr) 
OD600  
t = 36 h 
74D-694[pin-] pYES2 18.82 1.07 
74D-694[pin-] pYES2-RNQ1 20.16 1.09 
74D-694[PIN+]low pYES2 20.75 1.25 
74D-694[PIN+]low pYES2-RNQ1 25.96 0.41 
74D-694[PIN+]medium pYES2 20.29 1.17 
74D-694[PIN+]medium pYES2-RNQ1 24.81 0.63 
74D-694[PIN+]high pYES2 19.71 1.25 
74D-694[PIN+]high pYES2-RNQ1 33.63 0.53 
74D-694[PIN+]v. high pYES2 18.5 1.22 
74D-694[PIN+]v. high pYES2-RNQ1 32.71 0.56 
BY4741[PIN+] pYES2 3.87 2.08 





Similarly, the growth assays were also performed in the [PIN+] strains of 
BY4741. A growth defect was seen in the [PIN+] strain overexpressing Rnq1 
with a doubling time of 20 hours compared to about 4 hours in the control 
[PIN+] strain expressing the empty pYES2 plasmid (Table 4.1) The result 
confirmed that Rnq1 overexpression was toxic in a [PIN+] background of 





















Figure 4.4 Overexpression of Rnq1 leads to growth defects in different [PIN+] 
variants of 74D-694 cells. Cell density as measured by optical density of 600nm  
was determined in the inducing medium i.e. SD 2% galactose-ura for 48 hours at 
30°C. (a) Rnq1 overexpression did not cause a growth defect in [pin-] cells. (b) - (e) 
Rnq1 overexpression resulted in growth defects in the [PIN+] variants of 74D-694. (f) 
Rnq1 overexpression resulted in growth defects in the BY4741 [PIN+] strain. pYES2 
is the control plasmid while pYES2-RNQ1 is the pYES2 vector with RNQ1 insert. 





4.4 Rnq1-GFP forms fluorescent aggregates in [PIN+] cells 
 
 
In order to examine the [PIN+] status of the 74D-694 strains used in this study, 
the [pin-] derivative and four different [PIN+] derivatives of this strain  were 
each transformed with the plasmid pAG426 that encodes a Rnq1-GFP fusion 
(C-terminal GFP tag) under the galactose-inducible GAL1 promoter. The 
localization of Rnq1-GFP in 74D-694 [pin-] and [PIN+] cells was monitored by 
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Figure 4.5 Fluorescence of the Rnq1-GFP fusion protein in 74D-694-based [pin-] 
and [PIN+] cells. A uniform fluorescence was observed in [pin-] cells while [PIN+] 
cells with four different [PIN+] variants showed the appearance of aggregates of the 
fusion protein after 6 hours induction. Cells were grown in the inducing medium i.e. 
SD 2% galactose-ura for at 30°C. Samples were collected at time point 0 and 6 and 
visualised by a green excitation filter on an Olympus 1X81 fluorescent microscope 
with Hamamatsu Photonics Orca AG cooled CCD camera. Images were captured 
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Figure 4.6 Fluorescence of the Rnq1-GFP fusion protein was observed in 
BY4741-based [pin-] and [PIN+] cells. A uniform fluorescence was observed in [pin-] 
cells. The Rnq1-GFP fusion protein was detected within fluorescent foci in [PIN+] 
cells after 6 hours induction. NB: Each contains a number of images taken from 
different fields of viewing. 
 
 
In [pin-] cells, Rnq1-GFP showed diffuse fluorescence after 6 hours induction 
(t = 6) whereas in [PIN+] cells, this fusion protein was observed within 
fluorescent foci after 6 hours induction (t = 6). Moreover, the fluorescence 
pattern of different [PIN+] variants differed. The low [PIN+], medium [PIN+] and 
very high [PIN+] variants formed single fluorescence aggregates in 80% of 
cells whereas high [PIN+] variant showed multiple fluorescent foci in 80% of 
cells (Table 4.2). This result was consistent with previous findings published 
by Liebman et al., (2006). 
 
Unexpectedly, several small single or multiple fluorescent foci were observed 
before induction of expression of the Rnq1-GFP fusion by the addition of 
galactose i.e. t = 0. This may be caused by elevated expression of Rnq1 in 











Figure 4.7 Overexpression of Rnq1-GFP fusion protein was not toxic in 74D-
694 based [pin-] and [PIN+] strains. Cells were grown under the same conditions as 
toxicity assays of pYES2 and pYES2-RNQ1 strains (See section 4.2). 
 
Because the type of [PIN+] variant in the BY4741 strain had not previously 
been established (G.L.Staniforth, personal communication), the BY4741 [pin-] 
and [PIN+] strains were transformed with the pAG426 plasmid expressing a 
galactose-inducible Rnq1-GFP and the localization of Rnq1-GFP evaluated by 





diffuse fluorescence pattern as expected while in [PIN+] cells it formed 
multiple fluorescent aggregates indicating the [PIN+] variant in the yeast strain 
BY4741 is most likely a ‘high’ [PIN+] variant (Figure 4.6). 
 
As shown in Section 4.2, Rnq1 overexpression in a [PIN+] strain leads to 
cytotoxicity and so it was important to establish whether the overexpressed 
Rnq1-GFP fusion protein was also toxic. Consequently, overexpression of 
Rnq1-GFP was examined in plasmid AG426-RNQ1 transformants of [pin-] and 
four different [PIN+] derivatives of 74D-694. Interestingly, overexpression of 
Rnq1-GFP was neither toxic in [pin-] nor in any of the four [PIN+] derivatives 
(Figure 4.7). This loss of cytotoxicity may due to the structural change of 
Rnq1-GFP aggregates (C-terminal GFP tag) as a consequence of the 
26.9kDa GFP sequence added to the C terminus of Rnq1 (43kDa). 
 
Table 4.2 Quantitative analysis of the fluorescent aggregates formed in 
different [PIN+] variants at the 0 and 6 hour time points for each strain of 74D-
694 and BY4741 
 
[PIN+] variant No. cells 
analysed 
No. cells with 
aggregates 
T=0  
No. cells with 
aggregates 
T=6 
74D-694 [pin-] 98 3 (3%) 2 (2%) 
74D-694 [PIN+]LOW 95 10 (11%) 77 (80%) single 
74D-694 [PIN+]MED 95 13 (14%) 79 (83%) single 
74D-694 [PIN+]HIGH 97 7 (7%) 81(84%) multiple 
74D-694 [PIN+]VERY H. 93 4 (4%) 76 (82%) single 
BY4747 [pin-] 95 3 (3%) 4 (4%) 
BY4741 [PIN+] 100 9 (9%) 81 (81%) multiple  
 
 
4.5 Rnq1 overexpression causes a nuclear migration defect  
 
Since growth defects were found in [PIN+] cells when Rnq1 was 
overexpressed, further investigation into the factors that cause the observed 
growth defects was undertaken. Log phase 74D-694 cells were observed 
following staining with 4’,6-diamidino-2-phenylindole (DAPI) which is widely 
used to visualise nuclear DNA or mitochondrial DNA (Chazotte., 2011). The 





and pYES2-RNQ1 plasmids and overexpression of the RNQ1 gene induced 
by galactose. The nuclear DNA was visualized by fluorescence microscopy 
under ultraviolet light using DAPI to stain the DNA (Figure 4.8). Likewise the 
BY4741 strains were transformed with the pYES2-based plasmids and the 
galactose-inducible promoter GAL1 used to overexpress the Rnq1 protein. 
 
Overexpression of Rnq1 in BY4741 strain resulted in the localisation of 
nuclear DNA to the bud-neck 6 hours post induction of Rnq1 overexpression 
in this [PIN+] variant. This nuclear migration defect was not observed in the 
BY4741 [pin-] derivative (Figure 4.8). Such a nuclear migration defect would 
be expected to lead to a cell cycle blockage, as was subsequently reported by 
Treusch and Lindquist (2012). Rnq1 overexpression causes the Spc42 to be 
localised to the unduplicated spindle pole body (SPB) thus resulting in cell 
cycle arrest (Treusch and Lindquist, 2002). 
 
In 74D-694 [pin-] cells, the localization of nuclear DNA was similar with both 
pYES2 (control) and pYES2-RNQ1 strains before (t = 0) and after 6 hours 
induction (t = 6). This was observed in all four [PIN+] variants and thus no 
defect in nuclear migration was detected in the 74D-694 strains (Figure 4.9). 
 
These findings suggest that while the effect of different genetic backgrounds 
on Rnq1-induced cytotoxicity was negligible, there was an effect on nuclear 
division that was dependent on genetic background. Importantly, this would 
further suggest that the observed nuclear migration defect was not the cause 
of Rnq1-induced cytotoxicity. 












Figure 4.8 Overexpression of Rnq1 results in a nuclear migration defect in 
BY4741[PIN+] cells. Rnq1 overexpression leads to nuclear DNA localised to the 
bud-neck after 6 hours induction in pYES2-RNQ1[PIN+] strain whereas this was not 
observed in a [pin-] background. By contrast, the nuclear migration defects were not 






















Figure 4.9 Overexpression of Rnq1 does not lead to a nuclear migration defect 
in any of the 74D-694 [PIN+] variants. Rnq1 overexpression does not cause nuclear 
DNA localised to the bud-neck after 6 hours induction in all four [PIN+] variants. No 
the nuclear migration defects were detected in pYES2 control strains. Cells were 
visualised by a blue excitation filter on an Olympus 1X81 fluorescent microscope with 
Hamamatsu Photonics Orca AG cooled CCD camera. Images were captured 
analysed by Olympus CellR software. 
 
Table 4.3 Quantitative analysis of the nuclear migration defect in different [PIN+] 
variants at the 0 and 6 hour time points for each strain of 74D-694 and BY4741 
 


























74D pY-[pin-] 100 0 100 0 100 
74D pY-[PIN+]LOW 100 0 100 2 98 
74D pY-[PIN+]MED 100 1 99 2 98 
74D pY-[PIN+]HIGH 100 1 99 3 97 
74D pY-[PIN+]VERY H. 100 2 98 2 98 
74D pY-RNQ1[pin-] 100 0 100 0 100 
74D pY-RNQ1[PIN+]LOW 100 1 99 2 98 
74D pY-RNQ1[PIN+]MED 100 0 100 1 99 
74D pY-RNQ1[PIN+]HIGH 100 3 97 2 98 
74D pY-RNQ1[PIN+]VERY H. 100 2 98 5 95 
BY pY-[pin-] 100 3 97 2 98 





4.6 Rnq1 overexpression causes mitochondrial dysfunction in a [PIN+]-
dependent manner 
 
Since the Rnq1-induced toxic phenotype was observed in different [PIN+] 
variants, it was interesting to further investigate whether Rnq1 overexpression 
leads to defects in mitochondria.  Mitochondrial dysfunction can be detected 
by assaying the level of reactive oxygen species (ROS) in cells as 
mitochondria are believed to be the major intracellular source of ROS and 
ROS production is inherent in mitochondrial oxidative metabolism (DAutreaux 
and Toledano, 2007). 
 
The ROS assay used to evaluate mitochondrial dysfunction has been 
designed to measure the level of superoxide in cells with ROS production 
being estimated by following the oxidation of dihydroethidium (DHE). DHE is 
perhaps the most specific and least problematic dye as it detects essentially 
superoxide radicals, is retained well by cells, and may even tolerate mild 
fixation. Therefore, in order to explore whether Rnq1 overexpression leads to 
mitochondrial dysfunction, ROS assays (see Section 2.9.3) were performed 
on 74D-694-based [pin-] and the four [PIN+] variants before and after induction 
of overexpression of Rnq1. The level of superoxide in each strains was 
detected and quantified using a BD FACSCalibur flow cytometer and the 
results were analysed using BD CellQuest Pro Software. These data are 
shown in Figure 4.10. 
 
In the 74D-694 strains engineered to overexpress the RNQ1 gene, the level of 
superoxide was about five times higher after six hours induction than un-
induced cells. For example, the value of M2 (M2 indicates the amount of cells 
with mitochondrial defects) is 7.84 in un-induced very high [PIN+] cells while it 
is increased to 33.90 after six hours induction. The M2 value after induction 
divided by the M2 value before induction is 4.3 meaning that the amount of 
superoxide was about five times higher after six hours induction than un-
induced very high [PIN+] cells (This calculation was used in every strain in this 





to two-fold over in induced cells suggesting that Rnq1 overexpression causes 
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Figure 4.10 The level of superoxide generated by overexpression of Rnq1 as 
determined by flow cytometry. Marker (M1) represents the control peak which is 
used to establish the baseline fluorescence intensity. The peak shift to the right, 




In the [PIN+] BY4741 strain overexpressing the RNQ1 gene, a 20-fold 





compared with the control strain (pYES2). In un-induced cells overexpressing 
Rnq1, the level of superoxide was very close to the strain expressing the 
empty plasmid pYES2 (Figure 4.12). Thus, the same result of Rnq1 
overexpression leading to mitochondrial dysfunction in [PIN+] cells was 












Figure 4.11 Quantitative analysis of ROS production in different [PIN+] variants 
of 74D-694 strains engineered to overexpress Rnq1. The red bars indicate the 









Figure 4.12 Quantitative analysis of ROS production of [PIN+] variant of BY4741 
strains engineered to overexpress Rnq1. The red bars indicate the proportion of 










To further evaluate whether Rnq1 overexpression led to an ultrastructural 
defect in mitochondria that in turn resulted in the higher levels of ROS seen in 
74D-694-based [pin-] and four [PIN+] variants, transmission electron 
microscopy (TEM) of sectioned log phased cells was undertaken before and 
after 6 hours induction. The images obtained showed the structure of 
mitochondria was changed after six hours induction in four [PIN+] variants but 
not [pin-] (Figure 4.13). These changes were largely an elongation of the 
mitochondria and how they were stacked in the daughter cells i.e. there are 
several elongated mitochondria stacked at the bud neck as well as in the 
daughter cells. The abnormal morphologies of mitochondria confirm that Rnq1 
overexpression-induced elevated ROS levels could be due to mitochondrial 





















Figure 4.13 Cell ultrastructure of the 74D-694-based [PIN] variants. Cells were 
induced in galactose medium at 30°C for 6 hours. The structure of mitochondria was 
changed after 6 hours induction in low [PIN+], medium [PIN+], high [PIN+] and very 







As the results shown previously, Rnq1 overexpression is toxic in [PIN+] 
variants and leads to mitochondrial dysfunction in [PIN+] cells. However, the 
same phenotype was not found in [pin-] cells. Moreover, these findings were 
confirmed in different a genetic background i.e. the 74D-694 and BY4741 
strains. This suggests that the mitochondrial dysfunction is associated with 
Rnq1 overexpression in a [PIN+] background but not due to the loss of the 
cellular function of Rnq1 when it switches into a presumably non-functional 
amyloid form. Although a number of studies were carried out to explore the 
defects in mitochondrial function, the exact mechanism of mitochondrial 
dysfunction is still unclear. One possible explanation could be that Rnq1, as 
an intrinsically disordered protein, randomly interacts with other proteins 
resulting in disturbance in the cellular protein network, for example, actin 
cytoskeleton (Vavouri et al., 2009). Changes in actin cytoskeleton may cause 
alterations in mitochondrial morphology and dysfunction.     
 
However, the nuclear migration defect was only found in the BY4741 [PIN+] 
strains while the Rnq1 overexpression-induced cytotoxicity was observed in 
both BY4741 and 74D-694 strains in a [PIN+] background. This suggests that 
the toxic phenotype induced by Rnq1 overexpression does not dependent on 
the nuclear migration defect. Although Rnq1 overexpression mediated 
cytotoxicity is not caused by the nuclear migration defect, it is still interesting 
to explore why overexpression of Rnq1 results in nuclear migration defect in 
BY4741 [PIN+] background. It was established that Spc42, a highly 
phosphorylated coiled-coil protein at the core of the spindle pore body (SPB) 
(Bullitt et al., 1997), is specifically sequestered by Rnq1 overexpression 
resulting in a defect in the duplication of SPB. SPB plays a very important role 
in many essential mitotic processes, such as nuclear migration, spindle 
formation and chromosome movement (Byers and Goetsch, 1975). It has 
been found that Spc42 is localised to two foci i.e. duplicated SPB in budded 
cells in [pin-] background, while Spc42 is localised to a single focus i.e. 





can reduce the cytotoxicity caused by Rnq1 overexpression as the effect of 
Rnq1-mediated sequestration is overcome by an increased amount of Spc42 




































Chapter 5  
 
[PIN+]-dependent toxicity mediated by the 






















Proteins containing polyglutamine (polyQ) expansions lead to nine 
neurodegenerative diseases as the misfolded proteins have an impact on 
proper cellular function and result in cytotoxicity.  Despite distinct polyQ 
expansion proteins being associated with different polyQ disorders, an 
expansion of a trinucleotide repeat CAG encoding a polyQ tract is the 
pathogenic agent of all of these polyQ disorders. Although there is intense 
research underlying the pathogenicity of these diseases, the mechanism of 
polyQ disorders at least at a molecular level, still remains unclear.  
 
During the past ten years, several models were developed to investigate 
polyQ cytotoxicity such as the invertebrate Caenorhabditis elegans models, 
Drosophila models and yeast Saccharomyces cerevisiae models. For 
example, polyQ-YFP fusion protein was found to be toxic in C. elegans body 
wall muscle cells suggesting that polyQ tract is linked to the associated 
toxicity (Morley et al., 2002). The cytotoxicity of polyQ tract had been 
demonstrated in Drosophila model in 2005 (McLeod et al., 2005). The first 
yeast model was developed by Meriin in 2002 who established a direct link 
between the aggregation of polyQ tract and its cytotoxicity (Meriin et al., 2002). 
Moreover, a yeast model was used to determine the pathologies of polyQ 
disorders influenced by the intramolecular and intermolecular factors 
associated with polyQ expansion proteins (Lindquist et al., 2006). Recent 
studies revealed that interaction between Sup35 and polyQ tract via its prion 
domain plays an important role in polyQ toxicity when [PSI+] is present (Gong 
et al., 2012). 
 
Huntington disease is one of the nine fatal neurodegenerative polyQ disorders 
which is caused by a polyQ expansion in the huntingtin (Htt) protein resulting 
in protein aggregation (Ross and Tabrizi, 2011). A previous study had 
revealed that overexpression of polyQ leads to cytotoxicity in a [PIN+] 
background (Meriin et al., 2002). Since the Rnq1 protein is rich in 





dependent manner (Douglas et al., 2008), it was interesting to compare polyQ 
expansion protein mediated cytotoxicity with Rnq1 mediated cytotoxicity in 
different [PIN+] variants.  
 
In this chapter, a yeast-based Huntington disease model was used to 
investigate the mechanism of polyQ toxicity. Similarly, a series of cellular 
assays were employed to determine the mechanism of polyQ expansion 
protein-mediated cytotoxicity dependent upon the [PIN+] prion. 
 
 
5.2 Overexpression of a polyQ expansion protein HttQ103 is toxic in 
different [PIN+] variants but not in a [pin-] background   
 
In order to examine the toxic phenotype in different [PIN+] variants when a 
polyQ expansion protein was overexpressed, the two plasmid pYES2-Q25 
(control) and pYES2-Q103 obtained from Y. Chernoff (Meriin et al., 2002) 
were separately transformed into a [pin-] derivative and four different [PIN+] 
derivatives of yeast strain 74D-694 (Derkatch et al., 1997). As described in 
Chapter 4 (Section 4.2), cells were grown under the same conditions as 
strains harbouring pYES2 or pYES2-RNQ1. Q25 and Q103 were inserted into 
the pYES2 plasmid by Y. Chernoff (Meriin et al., 2002) placing expression of 
the Q25 and Q103 proteins under the control of a galactose inducible 
promoter GAL1. Strains expressing Q25 and Q103 were serially diluted and 
spotted onto different agar plates to assess growth (Figure 5.1). 
 
As previously reported (Meriin et al., 2002), Overexpression of Q103 was not 
toxic in a [pin-] strain whereas it was toxic in all four different [PIN+] variants. 
By contrast, overexpression of Q25 was neither toxic in [pin-] nor [PIN+] 
background. Interestingly, the low [PIN+] variant showed the highest degree of 
cytotoxicity when Q103 was overexpressed. This is different from the Rnq1-
mediated cytotoxicity reported in Chapter 4 where overexpression of Rnq1 

















Figure 5.1 Overexpression of Q103 results in different degrees of cytotoxicity 
in different [PIN+] variants of 74D-694 cells. Cells were grown in the inducing 
medium i.e. SD 2% galactose-ura for 8 hours at 30°C with shaking and diluted and 
spotted onto different agar plates. (a) Q103 overexpression was not toxic in [pin-] 
variant. (b) (c) (d) (e) Q103 overexpression was toxic in all four [PIN+] strains. 
polyQ25 presents the pYES2 plasmid with Q25 insert (control) while polyQ103 
presents the pYES2 vector with Q103 insert. Three biological replicates were 











Since Rnq1 overexpression-induced cytotoxicity was examined in two 
different yeast stains 74D-694 and BY4741, overexpression of Q103 
mediated cytotoxicity was also determined in the [PIN+] strain of BY4741. The 
result of these assays showed that overexpression of Q103 was also toxic in 
these [PIN+] cells but not in a [pin-] derivative. Overexpression of Q25 was not 
toxic in either [PIN+] and [pin-] cells (Figure 5.2). Thus, the same result of 
Q103 overexpression mediated cytotoxicity was confirmed in the yeast strain 
BY4741 indicating that the different genetic backgrounds had no impact on 
the toxic phenotype.  
 
Overexpression of both Rnq1 and Q103 result in cytotoxicity in a [PIN+]-
dependent manner while Rnq1 and Q103 mediated cytotoxicity in different 
[PIN+] variants differed i.e. the very high [PIN+] variant showed the highest 
degree of cytotoxicity when Rnq1 was overexpressed while the low [PIN+] 
variant showed the highest degree of cytotoxicity when Q103 was 
overexpressed. This suggests that Rnq1 and polyQ mediated cytotoxicity in 
different [PIN+] variants may undertake different mechanisms. One possible 
reason is that the low [PIN+] variant, as a prion seed, is more efficient in the 






























Figure 5.2 Overexpression of Q103 results in [PIN+]-dependent cytotoxicity in 
BY4741 cells. Q103 overexpression was not toxic in [pin-] but toxic in [PIN+] strains. 
polyQ25 presents the pYES2 plasmid with Q25 insert (control) while polyQ103 







5.3 Overexpression of Q103 causes a growth defect in [PIN+] cells 
 
 
In order to confirm the results obtained from toxicity assays, growth assays 
were performed to quantify the impact of overexpression of Q103 on the 
growth rate of both [pin-] and [PIN+] 74D-694 strains. Cells were grown under 
the same conditions as strains overexpressing the Rnq1 protein (See section 
4.3). After washing off all the glucose-containing medium, cells were grown in 
the selective, inducing medium i.e. SD 2% galactose for 48 hours at 30°C. 
Readings of OD600 were recorded every hour using a Fluostar Omega 
microplate reader. The results of growth analysis confirm that overexpression 
of Q103 does not cause a growth defect in [pin-] cells but confirms a growth 
defect in all four [PIN+] strains. Overexpression of Q25 did not lead to a 
growth defect in the [PIN+] strains or the [pin-] derivative (Figure 5.3). The 
doubling time of the four different [PIN+] strains overexpressing Q103 is much 
higher than the corresponding [PIN+] strains overexpressing Q25. The [pin-] 
derivative of 74D-694 overexpressing Q25 or Q103 showed similar doubling 
time (Table 5.1). The same finding was observed in strains overexpressing 




















Figure 5.3 Q103 overexpression leads to growth defects in different [PIN+] 
variants of 74D-694 cells compared to a [pin-] derivative. Cell density was 
determined in the inducing medium i.e. SD 2% galactose-ura for 47 hours at 30°C. (a) 
Overexpression of Q103 did not cause a growth defect in [pin-] cells. (b) (c) (d) (e) 
Overexpression of Q103 resulted in growth defects in [PIN+] strains. (f) polyQ103 
overexpression resulted in growth defects in the BY4741 [PIN+] strain. polyQ25 
presents the pYES2 plasmid with Q25 insert (control) while polyQ103 presents the 
pYES2 vector with Q103 insert. Three biological replicates were performed for each 








Table 5.1 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of 74D-
694 and BY4741 
 
Strain Plasmid Doubling time (hour) 
OD600  
t = 47 hour 
74D-694[pin-] pYES2-Q25 15.94 1.25 
74D-694[pin-] pYES2-Q103 16.35 0.90 
74D-694[PIN+]low pYES2-Q25 14.54 1.00 
74D-694[PIN+]low pYES2-Q103 19.09 0.47 
74D-694[PIN+]medium pYES2-Q25 16.14 1.08 
74D-694[PIN+]medium pYES2-Q103 25.29 0.72 
74D-694[PIN+]high pYES2-Q25 17.49 1.18 
74D-694[PIN+]high pYES2-Q103 22.35 0.51 
74D-694[PIN+]v. high pYES2-Q25 18.47 1.24 
74D-694[PIN+]v. high pYES2-Q103 25.85 0.64 
BY4741[PIN+] pYES2-Q25 4.13 2.08 
BY4741[PIN+] pYES2-Q103 16.27 1.02 
 
 
5.4 Q103-GFP forms fluorescent aggregates in [PIN+] cells 
 
 
As Rnq1-GFP forms fluorescent aggregates in [PIN+] cells and it is known to 
modulate HTT aggregates, it was interesting to further investigate whether 
overexpression of Q103 is able to form fluorescent aggregates in different 
[PIN+] variants. Q25 and Q103 were fused in frame with a GFP tag at C-
terminus while a FLAG tag was present at the N-terminus of each construct 
(Meriin et al., 2002). The localization of Q25-GFP and Q103-GFP in 74D-694 
[pin-] and [PIN+] cells was monitored by fluorescence microscopy (Figure 5.4). 
 
In both [pin-] and [PIN+] cells, Q25-GFP showed diffuse fluorescence after 6 
hours induction (t = 6) as expected. By contrast, in [PIN+] cells expressing 
Q103-GFP, the fusion protein was observed within fluorescent foci after 6 
hours induction (t = 6). However, several small single or multiple fluorescent 
foci were observed before induction of galactose (t = 0). This may be caused 
by low levels of expression of Q103 in the repressing glucose medium since 






As discussed in Chapter 4, the fluorescence pattern of different [PIN+] variants 
are differed when Rnq1 was overexpressed i.e. the high [PIN+] variant 
showed multiple fluorescent foci while the low [PIN+], medium [PIN+] and very 
high [PIN+] variants formed single fluorescence aggregates. However, all four 
different [PIN+] variants formed multiple Q103-GFP foci in 80% of cells in 
Q103 strains. 
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Figure 5.4 Fluorescence of the Q103-GFP fusion protein was observed in 74D-
694-based [pin-] and [PIN+] cells. A uniform fluorescence was observed in [pin-] 
cells while [PIN+] cells with four different [PIN+] variants in the appearance of 
aggregates of the fusion protein after 6 hours induction. Cells were grown in the 
inducing medium i.e. SD 2% galactose-ura for at 30°C. Samples were collected at 
time point 0 and 6 and visualised by a green excitation filter on an Olympus 1X81 
fluorescent microscope with Hamamatsu Photonics Orca AG cooled CCD camera. 





5.5 Overexpression of Q103 does not lead to a nuclear migration defect  
 
As described in Chapter 4 (Section 4.5), Rnq1 overexpression causes a 
nuclear migration defect in [PIN+] cells of strain BY4741. Thus, whether 
overexpression of Q103 leads to a nuclear migration defect was observed in 
parallel by fluorescence microscope with 4’,6-diamidino-2-phenylindole (DAPI) 
staining. Q25 and Q103 fused with a GFP tag at the C-terminus (Meriin et al., 
2002) were each transformed with [pin-] and [PIN+] cells of strain BY4741 and 
the [pin-] derivative and four different [PIN+] variants of 74D-694. The 
constructs were induced under the control of a GAL1 prompter i.e. 
overexpression of Q103 was induced by galactose. 
 
The fluorescence images showed that overexpression of Q103 does not have 
any impact on the localisation of nuclear DNA in either [pin-] or [PIN+] cells of 
strain BY4741 6 hours post induction by Q103 overexpression. As expected, 
the [pin-] or [PIN+] cells expressing Q25 (control) also do not exhibit any 
aberrant localisation of nuclear DNA (Figure 5.5). This suggested that Q103 











Figure 5.5 Overexpression of Q103 does not cause a nuclear migration defect 
in BY4741[PIN+] cells. Cells overexpressing Q103 showed normal localisation of 
nuclear DNA Rnq1 after 6 hours induction in both [pin-] and [PIN+] background. Cells 
were visualised by a blue excitation filter on an Olympus 1X81 fluorescent 
microscope with Hamamatsu Photonics Orca AG cooled CCD camera. 


























Figure 5.6 Overexpression of Q103 does not cause a nuclear migration defect 
in 74D-694-based [PIN+] cells. Q103 overexpression does not cause nuclear DNA 
localised to the bud-neck after 6 hours induction in all four [PIN+] variants. No nuclear 
migration defects were detected in strains expressing Q25 (control). Cells were 
visualised by a blue excitation filter on an Olympus 1X81 fluorescent microscope with 
Hamamatsu Photonics Orca AG cooled CCD camera. Images were captured 
analysed by Olympus CellR software. 
 
Likewise, the same phenotype was observed in 74D-694 cells. The [pin-] 
derivative and four different [PIN+] variants showed similar localization of 
nuclear DNA before (t = 0) and after 6 hours induction (t = 6) by the 
overexpression of Q103. The nuclear DNA did not stack on the bud-neck of 
the cell. This observation indicated that Q103 overexpression does not lead to 
a nuclear migration defect in 74D-694 strains (Figure 5.6).  
 
The nuclear migration defect was not observed in either BY4741 or 74D-694 
[PIN+] strains when Q103 was overexpressed, but overexpression of Q103 is 
toxic in [PIN+] strains of both BY4741 and 74D-694. This finding would 






Table 5.3 Quantitative analysis of the nuclear migration defect mediated by 
overexpression of polyQ103 in different [PIN+] variants at the 0 and 6 hour time 
points for each strain of 74D-694 and BY4741 
 
 


























74D Q25-[pin-] 100 0 100 1 99 
74D Q25-[PIN+]LOW 100 1 99 2 98 
74D Q25-[PIN+]MED 100 1 99 3 97 
74D Q25-[PIN+]HIGH 100 1 99 3 97 
74D Q25-[PIN+]VERY H. 100 3 97 2 98 
74D Q25-RNQ1[pin-] 100 0 100 0 100 
74D Q103-[PIN+]LOW 100 0 100 3 97 
74D Q103-[PIN+]MED 100 0 100 1 99 
74D Q103-[PIN+]HIGH 100 3 97 2 98 
74D Q103-[PIN+]VERY H. 100 1 99 2 98 
BY Q103-[pin-] 100 3 97 2 98 
BY Q103-[PIN+] 100 1 99 5 95 
 
 
5.6 Overexpression of Q103 does not lead to mitochondrial dysfunction 
in a [PIN+] background 
 
Previous studies revealed that overexpression of polyQ103 resulted in a 
deficiency in mitochondrial respiratory chain complex II and III that induced a 
significant increase in the production of reactive oxygen species (ROS) in 
cells overexpressing polyQ103 (Sloans et al., 2006). It was interesting to 
further investigate whether polyQ103 overexpression leads to deficiency in 
mitochondria in different [PIN+] variants that may contribute to the polyQ103-
mediated toxicity. 
 
As described in Section 4.6, ROS assays (see Section 2.9.3) were performed 
on 74D-694-based [pin-] and the four [PIN+] variants before and after induction 
of overexpression of polyQ103. The reactive oxygen species (ROS) assay 





level of superoxide in cells with ROS production being estimated by following 
the oxidation of dihydroethidium (DHE). The level of superoxide in each strain 
was detected and quantified using a BD FACSCalibur flow cytometer and the 
results were analysed using BD CellQuest Pro Software. These data 
(histograms) are shown in Figure 5.7. 
 
In the 74D-694 strains overexpressing polyQ103, the level of superoxide was 
about 10 times higher after six hours induction than un-induced cells. 
However, in the control strain (pYES2-Q25), there was also a 6 to 12-fold 
increase of the superoxide levels in the induced cells overexpressing polyQ25 
suggesting that polyQ103 overexpression does not cause a degree of 
mitochondrial dysfunction in the presence of [PIN+] (Figure 5.8). In addition, 
similar result was also found in the [PIN+] BY4741 strain (Figure 5.9). The 
opposite finding might be due to inadequate incubation time or effect of GFP 
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Figure 5.7 The level of superoxide generated by overexpression of polyQ103 as 
determined by flow cytometry. Marker (M1) represents the control peak which is 
used to establish the baseline fluorescence intensity. The peak shift to the right, 







Figure 5.8 Quantitative analysis of ROS production of [PIN+] variant of BY4741 
strains engineered to overexpress polyQ103. The red bars indicate the proportion 

















Figure 5.9 Quantitative analysis of ROS production in different [PIN+] variants 
of 74D-694 strains engineered to overexpress polyQ103. The red bars indicate 





A number of studies has revealed that defects in mitochondrial function play 
an essential role in the pathogenic mechanism of Huntington's disease (HD) 
as well as yeast models of HD. However, the results of the current study show 
that polyQ103 overexpression does not cause a degree of mitochondrial 
dysfunction in the presence of [PIN+]. A possible reason for this conflicting 
result is that experiments were performed under inadequate conditions for this 
effect to take place. 
 
Firstly, in experiments performed by Solans et al (2006) using yeast models, it 
was found that the level of ROS was significantly elevated in cells where 
polyQ103 was overexpressed. Cell respiration was attenuated after 4-6 hours 
of induction and decreased to 50% of the control after induction for 10 hours. 
This suggests that the defect in cell respiration may be caused by a change in 





However, in the current study, cells were induced by galactose only for 6 
hours thus more incubation time could have been required for the strain used.      
  
Secondly, ROS assays were performed on both [PIN+] 74D-694 and BY4741 
strains which were transformed with plasmid p6431 that had the GFP tag only. 
There was an 8-10 fold increase of the superoxide levels in both induced and 
un-induced cells (data not shown). This suggests that the GFP tag on the 
polyQ25 and polyQ103 fragment has a significant effect in detection of ROS.  
 
Thirdly, it was also established that overexpression of polyQ103 has an 
impact on mitochondrial morphology and distribution. The polyQ103 
aggregates may interact with proteins in the mitochondrial protein network 
leading to a progressive disruption of the actin cytoskeleton therefore causing 
an alteration of mitochondrial morphology (Ocampo et al., 2010). However, in 
this study, the ultrastructure of [PIN+] variants has not been examined to 
further evaluate whether polyQ103 overexpression can lead to defects in the 
mitochondria. In summary, whether overexpression of Q103 leads to 












Chapter 6  
 
The role of modifier genes in both Rnq1- 






















Proteins perform their functions in a cell not only depending on their own 
intrinsic properties but also influenced by physical and/or functional 
interactions with other proteins. Such protein interactions result in a protein 
network in the cell that underlies distinct cellular mechanisms. Thus the 
toxicity induced by a certain protein might be due to interactions between this 
particular protein and other proteins. It is therefore important to identify genes 
whose products might enhance or reduce amyloid toxicity in yeast.  
  
As described in Chapter 5, overexpression of polyQ expansion proteins 
derived from the Htt exon 1 fragment causes cytotoxicity in a [PIN+] 
dependent manner in the yeast Huntington’s model (Meriin et al., 2002). In 
2009, a modulator of polyQ toxicity in Drosophila, the upf1 protein, was 
identified by a high-throughput RNAi screen (Doumanis, 2009). Moreover, 
preliminary data established by Gemma Staniforth in our laboratory showed 
that deletion of the UPF1 gene suppressed both overexpression of Rnq1 and 
polyQ expansion protein mediated cytotoxicity (Staniforth., 2011). This finding 
made the upf1 protein a potential candidate to further investigate the 
mechanism of Rnq1- and polyQ- induced toxicity and the role of other cellular 
factors. 
 
In S. cerevisiae, three proteins namely Upf1, Upf2 and Upf3 (Leeds et al., 
1991; Cui et al., 1995; He and Jacobson, 1995) are key components of the 
nonsense-mediated mRNA decay (NMD) pathway which recognizes and 
destroys aberrant mRNAs containing premature termination codons (PTCs). 
The three conserved Upf proteins function as the Upf1–Upf2–Upf3 
surveillance complex that is associated with nonsense codon recognition on 
the ribosome, the mRNA decapping complex and the release factors eRF1 
and eRF3 (Swisher and Parker., 2011). Recent studies have revealed that 
deletion of the UPF1 or UPF2 genes results in increased viability of cells 
containing mutant termination factors as deletion of either UPF1 or UPF2 





In the Upf complex, the Upf1 protein acts as the essential regulator of NMD 
while Upf2 works as a scaffolding protein that connects Upf1 and Upf3 
(Chamieh et al., 2008). Thus it was interesting to investigate whether the 
whole Upf complex or the single Upf protein may regulate amyloid toxicity in 
yeast. In this chapter, a series of cell-based assays coupled with fluorescence 
microscopy were used to explore the role of the Upf1/2/3 proteins in Rnq1- 
and polyQ-mediated toxicity. 
 
 
6.2 Rnq1 and polyQ overexpression-mediated cytotoxicity is suppressed 
in XSI¨ and XSI¨ [PIN+] strains but not in XSI¨ [PIN+] strain  
 
Since the Upf1/2/3 proteins play a very important role in the NMD pathway as 
a complex (Leeds et al., 1991; Cui et al., 1995; He and Jacobson, 1995) and 
deletion of the UPF1 gene suppresses the overexpression of Rnq1- and 
polyQ-mediated cytotoxicity (Staniforth., 2011), it was interesting to further 
investigate whether deletion of UPF2 or UPF3 can also suppress the Rnq1- 
and polyQ-induced toxicity.  
 
To test this, [pin-] and [PIN+] derivatives of XSI¨ or XSI¨ or XSI¨ deletions 
in the strain BY4741 were each transformed with either the pYES2 (control) or 
the pYES2-RNQ1 plasmids. Toxicity assays (Section 4.1) were then 
conducted with these deletion strains (Figure 6.1). Similarly, pYES2-Q25 
(control) or pYES2-Q103 plasmids were each transformed into these XSI¨
deletion strains of BY4741 in order to establish if suppression of Rnq1 toxicity 
by the respective XSI¨ deletions was specific to the Rnq1 protein or also 





















Figure 6.1 Overexpression of Rnq1-induced toxicity is suppressed in XSI¨ and 
XSI¨ strains in a [PIN+] background. WT is the wild type UPF+ BY4741 strain. 
pYES2 is the control plasmid while RNQ1 is the pYES2 vector with RNQ1 insert. 
Rnq1 toxicity was examined on galactose plates since a galactose-inducible 
promoter GAL1 was used to overexpress the Rnq1 protein. ¼ YEPD and glucose 
plates served as controls for any growth defects. Rnq1 toxicity was tested in three 
deletion strains XSI¨, XSI¨ and XSI¨, compared to the wild type UPF+ BY4741 
strains. Three biological replicates were performed for each strain and one 
representative is shown for each. 
 
 
Both Rnq1 and polyQ overexpression were found not to be toxic in three 
deletion strains i.e. XSI¨ and XSI¨and XSI¨ in a [pin-] background as is 
also seen in the UPF+ [pin-] control. However, overexpression of Rnq1 and 
polyQ103 was toxic in wild type UPF+ and the XSI¨ strain in a [PIN+] 
dependent manner. Interestingly, both Rnq1 and polyQ103 mediated 
cytotoxicity is slightly enhanced in the XSI¨ strain in a [PIN+] background. 
This might be due to the function of Upf3 is distinct and different from Upf1 
and Upf2 as Upf3 has been recently identified a novel component in the 
degradation of mRNA in the nucleus (DNR) (Das et al., 2014). Importantly, 
Rnq1- and polyQ-mediated cytotoxicity was suppressed in the XSI¨ and 
XSI¨strains in a [PIN+] background (Figure 6.1/6.2). These findings suggest 
that the suppression of Rnq1 and polyQ toxicity is not due to the function of 
the UPF complex per se because the Upf3 protein is involved in the core 
machinery of NMD yet deletion of UPF3 gene did not suppress the 
overexpression of Rnq1- and polyQ-mediated toxicity. So this suggests that 
























Figure 6.2 PolyQ103-induced toxicity is also suppressed in XSI¨ and XSI¨ 
strains in a [PIN+] background. WT is the wild type UPF+ BY4741 strain. Q25 is the 
pYES2 based plasmid with a Q25 insert (control) while Q103 is the pYES2 based 
vector with a Q103 insert. Polyglutamine toxicity was examined on galactose plates 
since a galactose-inducible promoter GAL1 was used to overexpress the 
polyglutamine protein. ¼ YEPD and glucose plates served as controls for any growth 
defects. PolyQ toxicity was tested in three deletion strains XSI¨, XSI¨and XSI¨, 
compared to the wild type UPF+ BY4741 strains. Three biological replicates were 
performed for each strain and one representative is shown for each. 
 
 
6.3 [PIN+]-dependent growth defect caused by Rnq1 and polyQ103 
overexpression is suppressed in XSI¨ and XSI¨ strains but not in 
XSI¨ strain 
 
In order to further examine the cellular phenotype associated with 
overexpression of Rnq1 and polyQ, growth analysis was repeated in the 
XSI¨deletion [PIN+] strains of BY4741 to quantify the impact of Rnq1 and 
polyQ overexpression on the growth rate over a 36 hour period. As described 
in Chapter 4 (Section 4.3), cells were switched to galactose-containing 
medium after washing off the remaining glucose-containing medium and then 
grown for 36 hours at 30°C. Readings of culture de nsity (OD600) were 
recorded every hour using a Fluostar Omega microplate reader (Figure 6.3). 
 
The results obtained showed that overexpression of Rnq1 caused the 
expected growth defect in the wild type UPF+ BY4741 and also in the uSI¨
strain in a [PIN+] background. This was not found with the XSI¨and XSI¨
strains. In the XSI¨ and XSI¨ [PIN+] strains overexpressing Rnq1, the 
doubling time was about 4 hours compared to 20 hours in BY4741 wild type 
UPF+ strain and 27 hours in the XSI¨strain (Table 6.1). The shorter doubling 
time confirmed that Rnq1 overexpression was less toxic in the XSI¨ and 
XSI¨ [PIN+] strains. By contrast, there was no growth defect observed in 
BY4741 wild type UPF+ and all three upf deletion strains when the pYES2 
plasmid backbone was expressed (Figure 6.3). The doubling time of the 
corresponding control strain was similar (Table 6.1). These results confirmed 






In parallel, no growth defect of overexpression of the Q25 protein in the 
BY4741 [PIN+] wild type UPF+ and the three upf deletion strains was observed. 
The doubling time of each control strain was between 4 and 5 hours (Table 
6.1). By contrast, overexpression of polyQ103 led to a growth defect in the 
BY4741 wild type UPF+ [PIN+] strain and the upf3¨ [PIN+] strain while it was 
slightly recovered in the XSI¨ and XSI¨ in a [PIN+]-dependent manner 
(Figure 6.4). In the XSI¨and XSI¨[PIN+] strains overexpressing polyQ103, 
the doubling time was between 5 and 7 hours compared to approximately 16 
hours in the BY4741 wild type UPF+ [PIN+] strain and the XSI¨[PIN+] strain 
(Table 6.1).  
 
Similar to the [PIN+] strains overexpressing Rnq1, the shorter doubling time 
obtained in the XSI¨and XSI¨[PIN+] strains overexpressing polyQ103 also 
confirmed that polyQ103-mediated toxicity was suppressed  in XSI¨ and 
XSI¨ strains in a [PIN+] background. Moreover, according to the estimated 
doubling time, there is about a 5-fold increase in growth rate in the XSI¨and 
XSI¨  [PIN+] strains overexpressing Rnq1, while only 2-3-fold increase was 
observed in the XSI¨ and XSI¨  [PIN+] strains overexpressing polyQ103 
(Table 6.1). Thus the overall conclusion from these experiments is that 
suppression of Rnq1-mediated toxicity was greater than the suppression of 






















Table 6.1 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of BY4741. 
 
Strain Plasmid Doubling time (hr) 
OD600  
t = 36 h 
BY4741[PIN+] pYES2 3.87 2.08 
upf1¨[PIN+] pYES2 3.77 2.02 
upf2¨[PIN+] pYES2 4.42 2.04 
upf3¨[PIN+] pYES2 3.99 1.91 
BY4741[PIN+] pYES2-RNQ1 20.01 1.13 
upf1¨[PIN+] pYES2-RNQ1 4.98 2.18 
upf2¨[PIN+] pYES2-RNQ1 4.33 2.27 
upf3¨[PIN+] pYES2-RNQ1 27.57 0.89 
BY4741[PIN+] pYES2-Q25 4.13 2.08 
upf1¨[PIN+] pYES2-Q25 5.15 2.04 
upf2¨[PIN+] pYES2-Q25 4.66 2.25 
upf3¨[PIN+] pYES2-Q25 4.52 1.95 
BY4741[PIN+] pYES2-Q103 16.27 1.02 
upf1¨[PIN+] pYES2-Q103 7.83 1.85 
upf2¨[PIN+] pYES2-Q103 5.14 2.01 












Figure 6.3 Overexpression of Rnq1 does not lead to a growth defect in XSI¨ 
and XSI¨ strains in a [PIN+] background. Cell density was determined in the 
inducing medium i.e. SD 2% galactose-ura for 36 hours at 30°C. The effect of Rnq1 -
mediated toxicity was tested in three deletion strains XSI¨, XSI¨ and XSI¨, 
compared to the wild type UPF+ BY4741 strains. pYES2 is the control plasmid while 
RNQ1 is the pYES2 vector with RNQ1 insert. Three biological replicates were 









Figure 6.4 Overexpression of polyQ does not lead to a growth defect in XSI¨ 
and XSI¨ strains in a [PIN+] background. Cell density was determined in the 
inducing medium i.e. SD 2% galactose-ura for 36 hours at 30°C. The effect of polyQ -
mediated toxicity was tested in three deletion strains XSI¨, XSI¨ and XSI¨, 
compared to the wild type UPF+ BY4741 strains. Q25 is the pYES2 based plasmid 
with a Q25 insert (control) while Q103 is the pYES2 based vector with a Q103 insert. 




6.4 Expression of the wild type UPF1 gene in the XSI¨ strain restores 
both Rnq1- and polyQ103-induced toxicity 
 
In order to confirm the observed suppression of overexpression of Rnq1- 
induced toxicity by the XSI¨ strain was specific for the XSI¨ deletion, the 
UPF1 gene with its own promoter was cloned into the pAG415 plasmid 
(Staniforth, 2011). This was then used to determine whether expression of the 
wild type Upf1 protein in the XSI¨ strain restored the Rnq1- and polyQ103-
induced toxicity in a [PIN+] background. The pYES2 (control) or the pYES2-
RNQ1 plasmids were each co-transformed with the pAG415-UPF1 plasmid 





the pYES2-Q103 plasmids were also co-transformed with the pAG415-UPF1 











Figure 6.5 Suppression of the Rnq1 overexpression-induced toxicity in a XSI¨ 
strain is restored when the wild type Upf1 protein is expressed in a [PIN+] 
background. WT is the wild type UPF+ BY4741 strain. pYES2 is the control plasmid 
while RNQ1 is the pYES2 vector with RNQ1 gene insert. UPF1-RNQ1 is the co-
transformed strain expressing both Rnq1 and Upf1. Rnq1 toxicity was examined on 
galactose plates since the galactose-inducible promoter GAL1 was used to 
overexpress the Rnq1 protein. ¼ YEPD and glucose plates served as controls for 
any growth defects. Rnq1 toxicity was tested in the XSI¨ strain that was also 
expressing the Upf1 protein, compared to the wild type UPF+ BY4741 strain and the 
representative XSI¨ strain. Three biological replicates were performed for each 













As shown in Figure 6.5 and 6.6, overexpression of Rnq1 and polyQ103 was 
toxic in a [PIN+] background but this toxicity was supressed in a XSI¨[PIN+] 
strain. Expression of the wild type Upf1 protein in the XSI¨ strain partially 
restored the overexpression of Rnq1- and polyQ103-induced toxicity. One 
reason for the toxicity was partially restored rather than fully restored might be 
due to lower levels of the Upf1 protein. These findings confirmed that the 
suppression of Rnq1 and polyQ103 overexpression-mediated toxicity in the 
XSI¨[PIN+] strains was specific to the deletion of the UPF1 gene and not due 
to any secondary mutation that may have been introduced in a second gene 










Figure 6.6 Suppression of the polyQ103 overexpression-induced toxicity in a 
XSI¨ strain is partially suppressed when the wild type Upf1 protein is 
expressed in a [PIN+] background. WT is the wild type UPF+ BY4741 strain. Q25 is 
the pYES2 based plasmid with a Q25 insert (control) while Q103 is the pYES2 based 
vector with a Q103 insert. UPF1-Q103 is the co-transformed strain expressing both 
polyQ103 and Upf1. Polyglutamine toxicity was examined on galactose plates since 
the galactose-inducible promoter GAL1 was used to overexpress the polyglutamine 
protein. ¼ YEPD and glucose plates served as controls for any growth defects. 
PolyQ toxicity was tested in the XSI¨ strain that was also expressing the Upf1 
protein, compared to the wild type UPF+ BY4741 strain and the representative XSI¨ 
strain. Three biological replicates were performed for each strain and one 









6.5 Expression of the Upf1 protein in the XSI¨ strain shows the growth 
defects caused by Rnq1- and polyQ103 overexpression-mediated 
toxicity 
 
As described in Section 6.3, quantitative growth analysis was also carried out 
with the XSI¨ strain expressing the wild type Upf1 protein. The impact of 
overexpression of Rnq1 and polyQ103 on the growth rate in this strain was 
compared to the control wild type UPF+ and XSI¨ strains of BY4741 (Figure 
6.7). 
 
In strains carrying the control plasmid pYES2, the doubling time of the XSI¨ 
strain was similar to the strain expressing the wild type Upf1 protein, and to 
the wild type UPF+ strain of BY4741. This indicates that the three tested 
strains grew normally as expected although the slope of the growth curve of 
the XSI¨ strain expressing the wild type Upf1 protein was lower than the wild 
type UPF+ strain and the XSI¨ strain (Figure 6.7). 
 
In strains overexpressing the Rnq1 protein, a growth defect was seen in the 
wild type UPF+ strain as expected while the XIS¨ strain restored growth to 
that of the control (Figure 6.7). The doubling time of the XIS¨ strain 
expressing the pYES2 plasmid backbone was similar to the XIS¨ strain 
overexpressing the Rnq1 protein which was between 3.8 and 5.5 hours (Table 
6.2). Importantly, the XIS¨ strain also expressing the wild type Upf1 protein 
showed a partial growth defect compared to the wild type UPF+ strain 
overexpressing Rnq1. The doubling time of the XIS¨ strain expressing the 
wild type Upf1 was 9 hours while the wild type UPF+ strain showed a doubling 
time of 20 hours (Table 6.2). This indicates that suppression of Rnq1 toxicity 
in the XSI¨ strain was not fully restored when the wild type Upf1 protein was 
expressed. This finding is consistent with the result obtained from the toxicity 
assay described in Section 6.4. One reason for this difference might be due to 








Similarly, in strains overexpressing the polyQ103 protein, a growth defect was 
found in the wild type UPF+ strain with a doubling time of 16 hours while the 
XIS¨ strain restored this growth to the corresponding control strain (Figure 
6.7). The doubling time was 4 hours in the XIS¨ strain overexpressing Q25 
(control) and 7 hours in the XIS¨ strain overexpressing Q103 (Table 6.2). 
Likewise, the XIS¨ strain also expressing the wild type Upf1 protein showed 
a partial growth defect compared to the wild type UPF+ strain overexpressing 
Q103 with a doubling time of 10 hours a value between the wild type UPF+ 
strain and the XIS¨ strain (Table 6.2). This further suggests that suppression 
of polyQ103 toxicity in the XSI¨ strain was not fully restored when the wild 
type Upf1 protein was expressed. 
 
Table 6.2 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of BY4741. 
 
Strain Plasmid Doubling 
 time 
OD600 
t = 36 h 
BY4741[PIN+] pYES2 3.87 2.08 
upf1¨[PIN+] pYES2 3.77 2.02 
upf1¨[PIN+] pAG415-UPF1 + pYES2 4.81 1.59 
BY4741[PIN+] pYES2-RNQ1 20.01 1.13 
upf1¨[PIN+] pYES2-RNQ1 5.49 1.82 
upf1¨ [PIN+] pAG415-UPF1 + pYES2-RNQ1 9.09 1.26 
BY4741[PIN+] pYES2-Q25 4.17 2.08 
upf1¨[PIN+] pYES2-Q25 4.26 2.37 
upf1¨[PIN+] pAG415-UPF1 + pYES2-Q25 5.56 2.18 
BY4741 [PIN+] pYES2-Q103 16.27 1.02 
upf1¨ [PIN+] pYES2-Q103 7.83 1.85 











Figure 6.7 Overexpression of Rnq1 leads to a growth defect in the XSI¨ strain 
also expressing the wild type Upf1 protein in a [PIN+] background. Cell density 
was determined in the inducing medium i.e. SD 2% galactose-ura for 36 hours at 
30°C. The effect of Rnq1 toxicity was tested in the XSI¨ strain also expressing the 
wild type Upf1 protein, compared to the wild type UPF+ BY4741 and the XSI¨ strains. 
pYES2 is the control plasmid while RNQ1 is the pYES2 vector with RNQ1 insert. 










Figure 6.8 Overexpression of polyQ103 causes a detectable growth defect in 
the XSI¨ strain also expressing the wild type Upf1 protein in a [PIN+] 
background. Cell density was determined in the inducing medium i.e. SD 2% 
galactose-ura for 36 hours at 30°C. The effect of polyQ-mediated toxicity was tested 
in the XSI¨ strain also expressing the wild type Upf1 protein, compared to the wild 
type UPF+ BY4741 and the XSI¨ strains. Q25 is the pYES2 based plasmid with a 
Q25 insert (control) while Q103 is the pYES2 based vector with a Q103 insert. Three 







6.6 Rnq1 overexpression does not cause a nuclear migration defect in 
the XSI¨ and XSI¨strains 
 
As described in Section 4.5, overexpression of Rnq1 resulted in a nuclear 
migration defect in BY4741 [PIN+] cells. It was therefore interesting to 
investigate whether the nuclear migration defect was also observed in the 
XSI¨ and XSI¨ strains as Rnq1 overexpression-induced toxicity was 
supressed in the XSI¨ and XSI¨ strains. 
 
Log phase XSI¨ and XSI¨ cells of BY4741 were observed following staining 
with 4’,6-diamidino-2-phenylindole (DAPI) which is widely used to visualise 
nuclear DNA or mitochondrial DNA (Chazotte., 2011). The [PIN+] derivatives 
RI WKH XSI¨ DQG XSI¨ deletion strains of BY4741 were each transformed 
with either the pYES2 (control) or the pYES2-RNQ1 plasmids. The nuclear 
DNA was visualized by fluorescence microscopy under ultraviolet light using 
DAPI to stain the DNA (Figure 6.9).  
 
In the XSI¨ and XSI¨ strains overexpressing Rnq1, the localization of 
nuclear DNA was similar to that seen in strains expressing the pYES2 
backbone (control) before (t = 0) and after 6 hours induction (t = 6) and also 
similar with the un-induced cells i.e. (at t = 0). Thus no defect in nuclear 
migration was detected in the XSI¨ and XSI¨ [PIN+] strains (Figure 6.9). 
Although earlier findings reported in Chapter 4 (Section 4.5) concluded that 
Rnq1 overexpression-induced cytotoxicity is not associated with the nuclear 
migration defect (Section 4.5), the data shown in Figure 6.9 suggest that the 
Upf1 and Upf2 proteins might have a positive effect on nuclear migration 
and/or cell cycle control independent of Rnq1 overexpression mediated 
cytotoxicity since the nuclear migration defect would be expected to lead to a 










Figure 6.9 Overexpression of Rnq1 does not cause a nuclear migration defect 
in the XSI¨ and XSI¨ strains of BY4741 in a [PIN+] background. Rnq1 
overexpression does not cause nuclear DNA localised to the bud-neck after 6 hours 
induction in the XSI¨ and XSI¨ strains. No the nuclear migration defects were 
detected in pYES2 control strains. Cells were visualised by a blue excitation filter on 
an Olympus 1X81 fluorescent microscope with Hamamatsu Photonics Orca AG 







Figure 6.10 Overexpression of polyQ103 does not cause a nuclear migration 
defect in the XSI¨ and XSI¨ strains of BY4741 in a [PIN+] background. Rnq1 
overexpression does not cause nuclear DNA localised to the bud-neck after 6 hours 
induction in the XSI¨ and XSI¨ strains. No the nuclear migration defects were 
detected in pYES2 control strains. Cells were visualised by a blue excitation filter on 
an Olympus 1X81 fluorescent microscope with Hamamatsu Photonics Orca AG 





Likewise, the same experiments were carried out in parallel in BY4741 [PIN+] 
cells overexpressing polyQ103, however, polyQ103 overexpression did not 
cause a nuclear migration defect (see Chapter 5, Section 5.5) . In order to 
explore whether the Upf1 or Upf2 protein may cause a nuclear migration 
defect when polyQ103 was overexpressed, pYES2-Q25 (control) or pYES2-
Q103 plasmids were each transformed into the XSI¨and XSI¨ strains of  
BY4741. The nuclear DNA was visualized by fluorescence microscopy under 
ultraviolet light using DAPI to stain the DNA (Figure 6.10). 
 
As in the XSI¨ and XSI¨ strains overexpressing polyQ103, the localization 
of nuclear DNA was similar with strains overexpressing polyQ25 (control) 
before (t = 0) and after 6 hours induction (t = 6) and also similar with the un-
induced cells overexpressing polyQ103 (t =0). Therefore no defect in nuclear 
migration was detected in the XSI¨ and XSI¨ [PIN+] strains (Figure 6.10). 
This finding argues against the Upf1 or Upf2 proteins being associated with 
nuclear migration and/or cell cycle control. 
 
 
6.7 Construction of UPF1 mutations 
 
The UPF1 gene and its protein product have been intensively studied. The 
UPF1 gene encodes a 109-kDa protein which acts as an ATP-dependent 
RNA helicase. The Upf1 protein is rich in cysteine and histidine residues at its 
N-terminus representing the key feature of the RNA/DNA helicase superfamily 
group I (Koonin., 1992). The Upf2 protein interacts with this CH domain of 
Upf1 resulting in a conformational change of the CH domain that enhances 
the ATPase and helicase activity of Upf1 while reducing its ability to bind RNA 
(Clerici et al., 2009; Chakrabarti et al., 2011).  
Previous studies established that the ATPase and helicase activity of Upf1 
was affected by mutating the lysine residue in position 436 to any of the five 
residues which are alanine (A), glutamine (Q), aspartic acid (D), glutamic acid 
(E), and proline (P) respectively (Weng et al., 1996). This highly conserved 





other proteins (Fry et al., 1986). Thus the K436 mutations resulted in an 
impaired NMD pathway by inhibiting the functions of Upf1 in promoting mRNA 
decay (Weng et al., 1996).    
 
In addition to its role in ATP binding and hydrolysis, the CH domain of Upf1 
also act as a catalytic domain of the E3 ubiquitin ligase that in turn interacts 
with a specific E2 namely Ubc2 in yeast (Takahashi et al., 2008). Mutating the 
histidine (H) residue in position 94 to an arginine (R) in the CH domain results 
in an inhibition of the E3 ubiquitin ligase activity upon its interaction with Upf3 
(Takahashi et al., 2008). 
     
In order to identify which function of Upf1 is associated with overexpression of 
Rnq1- and polyQ103-induced toxicity, two mutated variants of Upf1, H94R 
and K436A, were created respectively using site-directed mutagenesis (See 
Section 2.X). Mutants were generated in a three step protocol. Firstly, the 
plasmid DNA pAG415-UPF1 and two oligonucleotide primers each 
complementary to opposite strands of the vector containing any of the desired 
mutation, (i.e. H94R or K436A), were used for synthesis of the mutant DNA 
strand by polymerase chain reaction (PCR). Then the Dpn I endonuclease 
was used to digest the parental DNA template which is methylated thus only 
the mutant-containing  DNA strand remains after digestion. Finally, the newly 
synthesised plasmid DNA with the desired mutation was transformed into 
XL1-Blue supercompetent E. coli cells. Four colonies of each putative mutant 
of Upf1 were purified and sent for sequencing (Section 2.6.6). All four tested 
DNA samples of each Upf1 mutant contained the desired amino acid residue 











Figure 6.11 Construction of UPF1 mutations using site-directed mutagenesis. A 
histidine (H) residue in position 94 was mutagenized to an arginine (R) and a lysine 
residue in position 436 was mutagenized to an alanine (A). Four DNA samples were 
tested for each mutation and one representative is shown for each. 
 
 
6.8 Expression of upf1 mutant genes in the XSI¨ strain partially 
suppress Rnq1 and polyQ overexpression-induced toxicity in [PIN+] 
cells 
 
As describe in Section 6.7, two single mutations i.e. H94R and K436A were 
generated respectively in the UPF1 gene of a pAG415-UPF1 plasmid. In 
order to explore either the ATPase and helicase activity or the E3 ubiquitin 
ligase activity of Upf1 is important for its role in Rnq1- and polyq103- 
mediated toxicity, the pYES2 (control) or the pYES2-RNQ1 plasmids were 
each co-transformed with the pAG415-UPF1 plasmid containing either H94R 
or K436A mutation into the XSI¨ [PIN+] strain (Figure 6.12). Similarly, the 
pYES2-Q25 (control) or the pYES2-Q103 plasmids were also co-transformed 
into a [PIN+] XSI¨ strain with the pAG415- upf1 plasmid expressing the 
desired upf1 mutant (Figure 6.13). Toxicity assays (Section 4.1) were then 
performed with these upf1 mutant strains (Figure 6.12, 6.13). 
 
As shown in Figure 6.12 and 6.13, overexpression of Rnq1 and polyQ103 was 
toxic in a [PIN+] background as expected while this toxicity was supressed in a 
XSI¨ [PIN+] strain as previously shown in Section 6.2. By comparison, 
expression of the H94R and K436A variants of the Upf1 protein in the XSI¨
strain partially restored the overexpressing of Rnq1- and polyQ103-induced 
toxicity to a similar seen when the wild type Upf1 protein was expressed in the 





Rnq1- and polyQ103-induced toxicity might be due to lower level of the wild 
type Upf1 expression. This result suggests that neither H94R nor K436A 
mutant of Upf1 has an impact on the Rnq1- and polyQ103-mediated toxicity 
indicating neither the ATPase and helicase activity nor the E3 ubiquitin ligase 
activity of Upf1 is associated with overexpression of Rnq1- and polyQ103-










Figure 6.12 Suppression of the Rnq1 overexpression-induced toxicity in a 
XSI¨ strain is partially restored when either the H94R or K436A Upf1 mutant 
proteins are expressed in a [PIN+] background. WT is the wild type UPF+ BY4741 
strain. pYES2 is the control plasmid while RNQ1 is the pYES2 vector with RNQ1 
insert. UPF1-RNQ1 is the co-transformed strain expressing both Rnq1 and Upf1. 
H94R-RNQ1 is the co-transformed strain expressing both Rnq1 and the H94R 
mutant Upf1. K436A-RNQ1 is the co-transformed strain expressing both Rnq1 and 
the K436A mutant Upf1. Rnq1 toxicity was examined on galactose plates since the 
galactose-inducible promoter GAL1 was used to overexpress the Rnq1 protein. ¼ 
YEPD and glucose plates served as controls for any growth defects. Rnq1 toxicity 
was tested in the XSI¨ strain that was also expressing the wild type and the two 
mutant Upf1 proteins, compared to the wild type UPF+ BY4741 strain and the 
representative XSI¨ strain. Three biological replicates were performed for each 















Figure 6.13 Suppression of the polyQ103 overexpression-induced toxicity in a 
XSI¨ strain is partially restored when any of the two mutant forms H94R and 
K436A of the Upf1 protein is expressed in a [PIN+] background. WT is the wild 
type UPF+ BY4741 strain. Q25 is the pYES2 based plasmid with a Q25 insert (control) 
while Q103 is the pYES2 based vector with a Q103 insert. UPF1-Q103 is the co-
transformed strain expressing both polyQ103 and Upf1. H94R-Q103 is the co-
transformed strain expressing both polyQ103 and the H94R mutant Upf1. K436A-
Q103 is the co-transformed strain expressing both polyQ103 and the K436A mutant 
Upf1. Polyglutamine toxicity was examined on galactose plates since the galactose-
inducible promoter GAL1 was used to overexpress the polyglutamine protein. ¼ 
YEPD and glucose plates served as controls for any growth defects. PolyQ toxicity 
was tested in the XSI¨ strain that was also expressing the wild type and the two 
mutant Upf1 protein, compared to the wild type UPF+ BY4741 strain and the 
representative XSI¨ strain. Three biological replicates were performed for each 





6.9 Expression of the mutant Upf1 protein in the XSI¨ strain shows the 
general growth defects 
 
In order to further investigate the cellular phenotype of the Upf1 mutants when  
Rnq1 or polyQ103 were overexpressed, quantitative growth analysis was 
repeated in the H94R and K436A mutants of the XSI¨ [PIN+] strain of 
BY4741 to quantify the impact of Rnq1 and polyQ overexpression on the 
growth rate. The result of the XSI¨ strain expressing the mutant Upf1 was 
compared with the wild type UPF+ strain, XSI¨ strain and the XSI¨ strain 
also expressing the wild type Upf1 protein (Figure 6.14, 6.15). The growth 
conditions were as described in Section 4.3. 
 
As expected, in strains carrying the pYES2 and pYES2-Q25 control plasmids, 
no growth defect was found in the wild type UPF+ strain, XSI¨ strain and  the 
XSI¨ strain expressing the wild type Upf1 protein (Figure 6.14, 6.15). The 
doubling time of these strains was between 3 to 5 hours (Table 6.3). However, 
a growth defect was seen in strains expressing the H94R and K436A mutant 
of Upf1 in the XSI¨ strain with a doubling time around 10 to 12 hours (Table 
6.3). 
 
By contrast, a growth defect was seen in the wild type UPF+ [PIN+] strain 
while the XIS¨ [PIN+] strain restored this growth to that of the control when 
Rnq1 or polyQ103 was overexpressed. The doubling time showed a 2 to 4-
fold increase in the wild type UPF+ strain overexpressing polyQ103 and Rnq1 
respectively when compared with the corresponding XIS¨ strain (Table 6.3). 
As described in Section 6.5, in XIS¨ [PIN+] strains also expressing the wild 
type Upf1 protein, a partial growth defect was seen when Rnq1 or polyQ103 
was overexpressed. Similarly, this partial growth defect was also found in 
strains expressing the H94R and K436A mutant of Upf1 in the XSI¨ [PIN+] 
strain (Figure 6.14, 6.15). According to the doubling time (Table 6.3), 
overexpression of Rnq1 and polyQ103 slightly elevated levels of toxicity in the 
XSI¨ [PIN+] strains compared to the XSI¨ [PIN+] strains expressing the wild 
type Upf1. Importantly, the doubling time of the constructs XSI¨ [PIN+] strain 





Rnq1 and polyQ103 (Table 6.3). Since the growth defect in the mutant XSI¨ 
[PIN+] strains overexpressing Rnq1 and polyQ103 was also found in strains 
expressing the pYES2 and pYES2-Q25, the overall conclusion is that the 
H94R and K436A mutants of Upf1 are generally toxic to cells, but not as a 
consequence of overexpression of Rnq1 or polyQ103. This finding also 
confirmed that overexpression of Rnq1- and polyQ103-mediated toxicity is not 
caused by either the ATPase and helicase activity or the E3 ubiquitin ligase 
activity of Upf1. 
 
Table 6.3 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of BY4741. 
 
Strain Plasmid Doubling 
 time 
OD600 
t = 36 h 
BY4741[PIN+] pYES2 3.87 2.08 
upf1¨[PIN+] pYES2 3.77 2.02 
upf1¨[PIN+] pAG415-UPF1 + pYES2 4.81 1.59 
upf1¨[PIN+] pAG415-UPF1_H94R + pYES2 11.28 1.02 
upf1¨[PIN+] pAG415-UPF1_K436A + pYES2 12.65 1.15 
BY4741[PIN+] pYES2-RNQ1 20.01 1.13 
upf1¨[PIN+] pYES2-RNQ1 5.49 1.82 
upf1¨[PIN+] pAG415-UPF1 + pYES2-RNQ1 9.09 1.26 
upf1¨[PIN+] pAG415-UPF1_H94R + pYES2-RNQ1 13.25 1.08 
upf1¨[PIN+] pAG415-UPF1_K436A + pYES2-RNQ1 15.35 0.98 
BY4741[PIN+] pYES2-Q25 4.17 2.08 
upf1¨[PIN+] pYES2-Q25 4.26 2.37 
upf1¨[PIN+] pAG415-UPF1 + pYES2-Q25 5.56 2.18 
upf1¨[PIN+] pAG415-UPF1_H94R + pYES2-Q25     10.83 1.30 
upf1¨[PIN+] pAG415-UPF1_K436A + pYES2-Q25  11.18 1.13 
BY4741 [PIN+] pYES2-Q103 16.27 1.02 
upf1¨[PIN+] pYES2-Q103 7.83 1.85 
upf1¨[PIN+] pAG415-UPF1 + pYES2-Q103 10.91 1.48 
upf1¨[PIN+] pAG415-UPF1_H94R + pYES2-Q103 11.66 1.25 










Figure 6.14 Expression of H94R or K436A mutants of Upf1 leads to a growth 
defect in the XSI¨ strain in a [PIN+] background independent of 
overexpression of Rnq1. Cell density was determined in the inducing medium i.e. 
SD 2% galactose-ura for 36 hours at 30°C. The effect of Rnq1 toxicity was tested in 
the XSI¨ strain expressing the H94R or K436A mutant Upf1, compared to the XSI¨ 
strain also expressing the wild type Upf1 protein, the wild type UPF+ BY4741 and the 
XSI¨ strains. pYES2 is the control plasmid while RNQ1 is the pYES2 vector with 
RNQ1 insert. Three biological replicates were performed for each strain and average 







Figure 6.15 Expression of H94R or K436A mutants of Upf1 leads to a growth 
defect in the XSI¨ strain in a [PIN+] background independent of 
overexpression of polyQ103. Cell density was determined in the inducing medium 
i.e. SD 2% galactose-ura for 36 hours at 30°C. The effect of polyQ toxicity was tested 
in the XSI¨ strain expressing the H94R or K436A mutant Upf1, compared to the 
XSI¨ strain also expressing the wild type Upf1 protein, the wild type UPF+ BY4741 
and the XSI¨ strains. Q25 is the pYES2 based plasmid with a Q25 insert (control) 
while Q103 is the pYES2 based vector with a Q103 insert. Three biological replicates 





6.10 Rnq1 and polyQ103 overexpression-mediated cytotoxicity is 
suppressed in a bna4¨ [PIN+] strain  
 
A second deletion strain namely EQD¨was also studied to further investigate 
the impact of different genetic modifiers on Rnq1- and polyQ103-mediated 
toxicity. Giorgini et al. (2005) discovered that deletion of the BNA4 gene 
strongly supressed polyQ103-induced toxicity in yeast. BNA4 encodes an 
enzyme, kynurenine 3-monooxygenase, which plays an essential role in 
tryptophan degradation via the mitochondrial kynurenine pathway (KP). 
Deletion of the BNA4 gene decreases the production two KP metabolites 
which are elevated in Huntington disease patients. Studies on the bna4¨ 
strain have provided a direct association between the pathogenesis of 
Huntington disease and cellular toxicity in the yeast model (Giorgini et al., 
2005).   
 
As overexpression of Rnq1- and polyQ103-mediated toxicity is suppressed in 
XSI¨ or XSI¨ strains (Section 6.2), it was interesting to examine whether 
deletion of BNA4 can also suppress the Rnq1-induced toxicity. To test this, 
[pin-] and [PIN+] derivatives of EQD¨ deletion in the strain BY4741 were each 
transformed with either the pYES2 (control) or the pYES2-RNQ1 plasmids. 
Toxicity assays (Section 4.1) were then conducted with this deletion strain 
(Figure 6.16). In comparison, the pYES2-Q103 plasmid was also transformed 
into the EQD¨ deletion strain of BY4741. In addition, the pYES2 empty 
plasmid was used as control strains for both Rnq1- and polyQ103 strains as 
the pYES2-Q25 plasmid did not transform successfully into the [pin-] or [PIN+] 
derivatives of the EQD¨ deletion strain of BY4741. The reasons for this could 
not be established. 
 
As expected, overexpression of Rnq1 and polyQ103 was not toxic to the 
EQD¨ [pin-] strain as is also seen in the UPF+ [pin-] control while it was toxic 
in the UPF+ [PIN+] strain (Figure 6.16). Importantly, both Rnq1- and polyQ103-











Figure 6.16 Overexpression of Rnq1- and polyQ103-induced toxicity is 
suppressed in the EQD¨ [PIN+] strain. WT is the wild type BNA4+ BY4741 strain. 
pYES2 is the control plasmid while RNQ1 is the pYES2 vector with RNQ1 insert. 
Q103 is the pYES2 based vector with a Q103 insert. Rnq1 and polyQ103 toxicity was 
examined on galactose plates since a galactose-inducible promoter GAL1 was used 
to overexpress the Rnq1 protein. ¼ YEPD and glucose plates served as controls for 
any growth defects. Rnq1 and polyQ103 toxicity was tested in the deletion strain 
bna4¨, compared to the wild type UPF+ BY4741 strains. Three biological replicates 





6.11 [PIN+]-dependent growth defect caused by Rnq1 and polyQ103 
overexpression is suppressed in the EQD¨ strain 
 
As described in Section 6.3, 36 hour growth analysis was repeated in the 
EQD¨deletion [PIN+] strains of BY4741 to quantify the impact of Rnq1 and 
polyQ overexpression on the growth rate. 
 
As previously found, overexpression of Rnq1 and polyQ103 caused a growth 
defect in the wild type BNA4+ [PIN+] strain of BY4741 while normal growth 
was observed in BY4741 wild type BNA4+ and the EQD¨ deletion strains 
when the control pYES2 plasmid backbone was expressed (Figure 6.17). In 
the bna4¨ [PIN+] strain overexpressing Rnq1 and polyQ103, growth was 
similar to that of expressing the control pYES2 plasmid thus confirming that 
the growth defect caused by Rnq1 and polyQ103 overexpression was 
suppressed in the EQD¨ [PIN+] strain. This result confirmed that Rnq1 and 














Figure 6.17 Overexpression of Rnq1 and polyQ103 does not lead to a growth 
defect in the EQD¨ [PIN+] strain. Cell density was determined in the inducing 
medium i.e. SD 2% galactose-ura for 36 hours at 30°C. The effect of Rnq1 and polyQ 
toxicity was tested in the [PIN+] deletion strain EQD¨, compared to the wild type 
BNA4+ BY4741 strains. pYES2 is the control plasmid while RNQ1 is the pYES2 
vector with RNQ1 insert. Q103 is the pYES2 based vector with a Q103 insert. Three 






Table 6.4 Doubling time in exponential growth and cell density measured by 
the optical density of 600nm at the 36 hour time point for each strain of BY4741. 
 
Strain Plasmid Doubling 
 time 
OD600 
t = 36 h 
BY4741[PIN+] pYES2 3.87 2.08 
bna4¨[PIN+] pYES2 3.57 2.09 
BY4741[PIN+] pYES2-RNQ1 20.01 1.13 
bna4¨[PIN+] pYES2-RNQ1 4.42 2.13 
BY4741 [PIN+] pYES2-Q103 16.27 1.02 
bna4¨ [PIN+] pYES2-Q103 6.9 2.00 
 
 
6.12 Rnq1 and polyQ103 overexpression does not cause a nuclear 
migration defect in the bQD¨ strain 
 
As described in Section 4.5 and 6.6, overexpression of Rnq1 resulted in a 
nuclear migration defect in BY4741 [PIN+] cells but not in the XSI¨ and XSI¨
[PIN+] cells. It was therefore interesting to investigate whether the nuclear 
migration defect was also observed in the EQD¨ strains as Rnq1 
overexpression-induced toxicity was supressed in the EQD¨ strain in a [PIN+] 
background. 
 
Similar to all strains used to observe the nuclear migration defect, log phase 
EQD¨ cells of BY4741 were stained with 4’,6-diamidino-2-phenylindole (DAPI) 
(Chazotte., 2011). The [pin-] and [PIN+] derivatives of the EQD¨ deletion 
strain were each transformed with either the pYES2 (control) or the pYES2-
RNQ1 plasmids. The DAPI-stained nuclear DNA was visualized by 
fluorescence microscopy under ultraviolet light (Figure 6.18).  
 
In the EQD¨ [PIN+] strain overexpressing Rnq1, the localization of nuclear 
DNA was similar with strains expressing the pYES2 backbone plasmid 
(control) before (t = 0) and after 6 hours induction (t = 6) and also similar with 
the un-induced cells overexpressing Rnq1 (t = 0). The same observation was 
also seen in the EQD¨ [pin-] strains (Figure 6.18). Thus no defect in nuclear 





overexpressed. As it was concluded that Rnq1 overexpression-induced 
cytotoxicity is not directly associated with a nuclear migration defect (Section 
4.5) and there was a nuclear migration defect in the wild type BNA4+ [PIN+] 
strain suggesting the Bna4 protein might not be related to nuclear migration or 
cell cycle control. 
 
The same experiments were also carried out in the log-phase BY4741 [PIN+] 
cells overexpressing polyQ103. However, polyQ103 overexpression did not 
cause a nuclear migration defect (see Section 5.5). In order to investigate 
whether deletion of the Bna4 protein may cause a nuclear migration defect 
when polyQ103 was overexpressed, pYES2-Q103 plasmid was transformed 
into both [pin-] and [PIN+] derivatives of the EQD¨ deletion strain of BY4741. 
The DAPI-stained nuclear DNA was visualized by fluorescence microscopy 
under ultraviolet light (Figure 6.18). 
 
In the EQD¨ strain overexpressing polyQ103, the localization of nuclear DNA 
was similar to that seen in strains overexpressing the pYES2 empty plasmid 
(control) before (t = 0) and after 6 hours induction (t = 6) and also similar with 
the un-induced cells overexpressing polyQ103 (t =0). Therefore no defect in 
nuclear migration was seen in the EQD¨ [PIN+] strain (Figure 6.18). This 
finding suggests that the Bna4 protein might not be associated with nuclear 



















Figure 6.18 Overexpression of Rnq1 and polyQ103 does not cause a nuclear 
migration defect in the EQD¨ strain of BY4741 in a [PIN+] background. Rnq1 
and polyQ103 overexpression do not cause nuclear DNA localised to the bud-neck 
after 6 hours induction in the EQD¨ strain. No the nuclear migration defects were 
detected in pYES2 control strains and the corresponding [pin-] strains. Cells were 
visualised by a blue excitation filter on an Olympus 1X81 fluorescent microscope with 
Hamamatsu Photonics Orca AG cooled CCD camera. Images were captured 






In the current study, the results show that Rnq1 and polyQ overexpression-
mediated cytotoxicity is suppressed in XSI¨ and XSI¨ [PIN+] strains but not 
in XSI¨ [PIN+] strain as well as the [PIN+]-dependent growth defect caused 
by Rnq1 and polyQ103 overexpression is suppressed in XSI¨ and XSI¨ 





and growth defect mediated by Rnq1 and polyQ103 is slightly enhanced in the 
XSI¨ strain in a [PIN+]-dependent manner. 
 
As far as we know, the upf proteins function as a complex which plays an 
important role in the nonsense-mediated mRNA decay (NMD) pathway. So 
the question is why the Upf3 protein is distinct from the Upf1 and upf2 
proteins in Rnq1 and polyQ103 mediated cytotoxicity and growth defects. 
 
According to the studies based on the degradation of mRNA, four different 
pathways have been established in Saccharomyces cerevisiae: (i) A major 
pathway degrades normal mature mRNAs through a major 5’-to-3’ manner 
(Decker and Parker, 1993; Tucker et al., 2001). (ii) Deadenylated mRNAs are 
subjected to 3’ė5’ degradation by the action of the exosome In the minor 
pathway (Mitchell et al., 1997). Both of the major and minor pathways take 
place in the cytoplasm. (iii) A specialized pathway, known as nonsense-
mediated mRNA decay (NMD) pathway, is a translation-coupled mechanism 
that eliminates mRNAs containing premature translation-termination codons 
(PTCs). The Upf1, Upf2 and Upf3 proteins are the key components of the 
conserved core of NMD pathway (Lelivelt and Culbertson, 1999). (iv) A novel 
pathway, named as Degradation of mRNA in the Nucleus (DRN), act on 
RNAs preferentially retained in the nucleus depending on the nuclear mRNA 
cap-binding protein, Cbc1p (Das et al., 2003). Recent studies revealed that 
the Upf3 protein is involved in the DRN pathway by employing a genetic 
screen (Das et al., 2014). Therefore, the Upf3 protein has been found to be 
involved in both NMD and DRN pathways indicating that it may possess a 
unique function which has an impact on Rnq1 and polyQ103 mediated 













































7.1 Overview of the project 
 
Many neurodegenerative diseases are associated with amyloids which are 
deposited in different tissues. Amyloids are formed by the seeded aggregation 
of proteins that, in the case of prions, can convert normal folded proteins into 
different heritable conformers of these proteins. Different prion variants cause 
different characteristics of the disease i.e. different pathologies. However, the 
mechanism of amyloid-mediated toxicity associated with these diseases still 
remains unclear. Moreover, at a molecular level, information about how 
different prion variants lead to distinct pathologies and how they are 
generated is still very limited.  Considerable insight into amyloid biology and 
toxicity has come from studies with the yeast Saccharomyces cerevisiae. 
 
In this thesis, I describe studies on four different variants of [PIN+], the prion 
form of the protein Rnq1. To further investigate Rnq1-mediated amyloid 
toxicity I compared the findings made with polyQ103-induced toxicity in the 
four different [PIN+] variants. The effects of genetic background on Rnq1- and 
polyQ103-induced toxicity were also investigated by comparing behaviour in 
two genetically unrelated yeast laboratory strains: BY4741 (a derivative of the 
standard laboratory strain S288c) and a strain derived from a Russian 
collection (74D-694). Furthermore, several deletion strains of the BY4741 
strain were used to further investigate the mechanism of Rnq1- and 




















Table 7.1 De novo formation of [PSI+] prion detected by different [PIN+] variants 
74D-694 strains 














































Table 7.2 Overexpression of Rnq1- and polyQ-mediated toxicity in BY4741 
[PIN+] strains 
BY4741[PIN+] Rnq1 overexpression Q103 overexpression 
Cytotoxicity Yes Yes 
Growth defect Yes Yes 
Fluorescence foci multiple dot multiple dot 
Nuclear migration defect Yes No 
ROS levels increased No  
UPF1 deletion suppresses toxicity suppresses toxicity 
UPF2 deletion suppresses toxicity suppresses toxicity 
UPF3 deletion toxic toxic 
Re-introducing UPF1 partially restored toxicity partially restored toxicity 
mutation H94R in UPF1 partially restored toxicity partially restored toxicity 

























Cytotoxicity not toxic Toxic toxic toxic toxic 
Growth 
defect No Yes Yes Yes Yes 
Fluorescen












No No No No No 









































Table 7.4 Overexpression of polyQ103-mediated toxicity in different [PIN+] 
variants of 74D-694 
 Q103 overexpression 
74D-694 
strains [pin







Cytotoxicity not toxic toxic toxic toxic toxic 
Growth 
defect No Yes Yes Yes Yes 
Fluoresenc












No No No No No 










7.2 Is the mechanism of amyloid toxicity the same for Rnq1 and 
polyQ103? 
 
Several studies have revealed that the Rnq1 and polyglutamine-containing 
proteins have many features in common that makes Rnq1 acts a powerful 
model for investigating the mechanism of the pathological amyloids such as 
polyQ103. For example, the Sis1 and Hsp104 chaperones involved in the 
propagation and maintenance of the [PIN+] prion was also established that 
were able to modulate the aggregation of polyglutamine proteins (Krobitsch 
and Lindquist, 2000). It has been shown that both Rnq1 and polyQ103 
overexpression is toxic in a [PIN+] background (Meriin et al., 2002, Chapter 4 
and 5) however, what types of protein conformation are toxic to cells has 
remained unclear. Rnq1 forms amyloid with the characteristic parallel in-
register cross-beta-sheet structure (Wickner et al., 2008) while the structure of 
polyQ-based amyloid has yet to fully elucidated. Most researchers thought 
that polyglutamines adopt an anti-parallel structure (Thakur and Wetzel, 2002, 
Sharma et al., 2005, Poirier et al., 2005, Zhang et al., 2011, Sivanandam et al., 
2011) although for another polyglutamine protein, ataxin-3, a parallel beta-
sheet structure was proposed by infrared spectroscopy (Bevivino and Loll, 
2001). Since the lengths of polyglutamine tracts vary between individual HD 
patients, the polyglutamine aggregates may contain both parallel and anti-
parallel beta-sheets structures. Moreover, it was established that polyQ 
fragments form an alpha-helical oligomer early in the aggregation process 
[Jayaraman et al., 2012]. Accordingly, as a consequence of the uncertainty of 
the secondary structure of the various polyglutamine proteins, it is 
conceivable that Rnq1 and polyQ103 may go through different pathways for 
their associated toxicity. Protein structure has a great influence on protein-
protein interactions that in turn might impact on cellular function leading to the 
toxic phenotype.    
In this study, four deletion strains (XSI¨, XSI¨, XSI¨ and EQD¨) were 
investigated with respect to both Rnq1 and polyQ toxicity. The same result 
has been found in these deletion stains i.e. Rnq1 and polyQ overexpression-





but not in XSI¨ [PIN+] strain. This suggests that one or more aspects of the 
mechanism of Rnq1 and polyQ103-mediated toxicity overlap, perhaps 
targeting some fundamental cellular process such as the mitochondrial 
kynurenine pathway for synthesis NAD+. 
 
7.3 Is mitochondrial deficiency a consequence of amyloid toxicity in 
yeast? 
 
Over the past 30 years, studies have demonstrated that mutant polyglutamine 
proteins associated with mitochondrial dysfunctions play an essential role in 
the pathogenesis of Huntington disease. In this study, an increase of ROS 
levels was not detected in either 74D-694 and BY4741 strains overexpressing 
polyQ103 by 6 hours post induction. One reason for the unexpected result is 
that the induction time was not sufficient.  
 
However, the levels of ROS did increase in cells overexpressing Rnq1 in a   
[PIN+] manner (Figure 4.11-12) suggesting that Rnq1 overexpression causes 
a degree of mitochondrial dysfunction. In addition, the observed aberrant 
morphology of mitochondrial ultrastructure in [PIN+] cells when Rnq1 was 
overexpressed (Figure 4.13) is consistent with this conclusion. This might be 
due to Rnq1 overexpression interfering with the cytoskeleton that would in 
turn impact on mitochondrial trafficking leading to changes in mitochondrial 
morphology and eventually mitochondrial dysfunction. 
 
 
7.4 Is nuclear migration defect a feature of amyloid toxicity? 
 
As summarised in Tables 7.2 - 7.4, a nuclear migration defect was only 
observed in the [PIN+] strain of BY4741 when Rnq1 was overexpressed. The 
fluorescence images obtained using DAPI to stain DNA showed that nuclear 
DNA localised to the bud-neck 6 hours post induction of Rnq1 overexpression 





mad2 deletion cells were arrested continued to synthesis DNA but not 
cytokinesis by Rnq1 overexpression indicating that Rnq1 overexpression 
induces a spindle checkpoint resulting in cell cycle arrest (Treusch and 
Lindquist, 2012). Moreover, a monopolar spindle was seen by electron 
microscopy in [PIN+] cells when Rnq1 was overexpressed suggesting that 
Rnq1 toxicity triggers a defect in spindle pole body duplication (Treusch and 
Lindquist, 2012). This would be expected to lead to a nuclear migration defect. 
 
By contrast, the nuclear migration defect was not observed in either BY4741 
or 74D-694 [PIN+] strains when Q103 was overexpressed. Since a nuclear 
migration defect would be expected to lead to a cell cycle blockage, cells 
overexpressing polyQ103 may undertake another mechanism that affects cell 
cycle blockage. For example, recent evidence has demonstrated that there 
was a defect in spindle extension process when polyQ56 is present. 
Importantly, the assembly of the septin ring was also interrupted resulting in a 
production of polyploid cells (Kaiser et al., 2013). 
 
Therefore, the cell cycle blockage triggered by Rnq1 or polyglutamine 
expansion proteins may do so via different mechanisms. Furthermore, there 
was an effect on nuclear migration by Rnq1 overexpression that was 
dependent on the genetic background of the strain in which the studies were 
carried out. Therefore a nuclear migration defect may not be a common 




7.5 Why dose Upf1 and Upf2 proteins suppress amyloid toxicity? 
 
In this study, overexpression of Rnq1 and polyQ mediated cytotoxicity was 
suppressed in both the XSI¨and XSI¨ [PIN+] strains. The Upf1 protein is a 
multifunctional protein that acts as an ATPase, an RNA helicase and a 
ubiquitin ligase (Czaplinski et al., 1995, Chamieh et al., 2008, Takahashi et al., 





inhibit the ATPase/helicase activity and the E3 ubiquitin ligase activity of Upf1 
respectively (Weng et al., 1996, Takahashi et al., 2008) did not ablate toxicity 
suggesting that these activities of Upf1 are not associated with 
overexpression of Rnq1 and polyQ103 mediated cytotoxicity. The Upf2 
protein acts as a bridge to connect the Upf1 and Upf3 proteins and the upf1, 
upf2 and upf3 function as a complex in the NMD machinery (He et al., 1997). 
However, overexpression of Rnq1 and polyQ was toxic in the XSI¨ [PIN+] 
strain suggesting that the NMD pathway has no impact on Rnq1 and 
polyQ103.  
So why is Rnq1 and polQ103-mediated amyloid toxicity suppressed in the 
upf1 and upf2 deletion strains but not the upf3 defective strain? One possible 
reason is that the Upf1 and Upf2 proteins interact with Rnq1 and polyQ103 
directly or indirectly thus facilitating the aggregation of Rnq1 and polyQ103 
thereby generating form toxic aggregates in a [PIN+] background. However, 
deletion of either upf1 or upf2 may affect the protein-protein interaction and 
thus Rnq1 and polyQ103 may tend to form inclusion bodies which are not 
toxic to the cell. 
Recent research was established that the Q-rich PrDs (prion forming domains) 
are able to suppress polyQ toxicity by interaction with the toxic oligomers and 
facilitates the formation of large non-toxic aggregates (Kayatekin et al., 2014). 
Another possible reason for why deletion of UPF1 and UPF2 genes 
suppresses amyloid toxicity is that a particular sequence in the Upf1 or Upf2 
(but not Upf3) plays a role in the formation of toxic oligomers which do not 
form in the absence of either protein. This sequence might give rise to a 
specific structure that inhibit or slow down the process for forming large 
nontoxic aggregates or degrade into monomeric proteins.  
 
7.6 Why does bna4¨ suppress amyloid toxicity? 
 
As described in chapter 6, Rnq1 and polyQ103 toxicity were suppressed in 
the EQD¨ [PIN+] strain. Ban4 encodes an enzyme that plays a key role in the 
mitochondrial kynurenine pathway for synthesis of NAD+. Overexpression of 





of 3-hydroxykynurenine (3-HK) and quinolinic acid which are two neurotoxic 
intermediates. Deletion of the BNA4 gene decreases the production of the two 
intermediate of KP that overcomes the toxicity of mutant polyQ proteins 
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